<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32196547</article-id>
<article-id pub-id-type="pmc">7372553</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddaa050</article-id>
<article-id pub-id-type="publisher-id">ddaa050</article-id>
<article-categories>
<subj-group subj-group-type="category-taxonomy-collection">
<subject>AcademicSubjects/SCI01140</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>General Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Novel truncating mutations in <italic>CTNND1</italic> cause a dominant craniofacial and cardiac syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alharatani</surname>
<given-names>Reham</given-names>
</name>
<!--<email>reham.al-haratani@kcl.ac.uk</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ververi</surname>
<given-names>Athina</given-names>
</name>
<!--<email>athina.ververi@nhs.net</email>-->
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beleza-Meireles</surname>
<given-names>Ana</given-names>
</name>
<!--<email>ana.beleza@gmail.com</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Weizhen</given-names>
</name>
<!--<email>weizhen.ji@yale.edu</email>-->
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mis</surname>
<given-names>Emily</given-names>
</name>
<!--<email>emily.mis@yale.edu</email>-->
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patterson</surname>
<given-names>Quinten T</given-names>
</name>
<!--<email>quinten.patterson@utsouthwestern.edu</email>-->
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Griffin</surname>
<given-names>John N</given-names>
</name>
<!--<email>john.griffin@uea.ac.uk</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhujel</surname>
<given-names>Nabina</given-names>
</name>
<!--<email>nabina.bhujel@gstt.nhs.uk</email>-->
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-4088-6673</contrib-id>
<name>
<surname>Chang</surname>
<given-names>Caitlin A</given-names>
</name>
<!--<email>caitlin.chang@albertahealthservices.ca</email>-->
<xref ref-type="aff" rid="aff9">9</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dixit</surname>
<given-names>Abhijit</given-names>
</name>
<!--<email>abhijit.dixit@nuh.nhs.uk</email>-->
<xref ref-type="aff" rid="aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Konstantino</surname>
<given-names>Monica</given-names>
</name>
<!--<email>Monica.Konstantino@yale.edu</email>-->
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Healy</surname>
<given-names>Christopher</given-names>
</name>
<!--<email>christopher.healy@kcl.ac.uk</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hannan</surname>
<given-names>Sumayyah</given-names>
</name>
<!--<email>sumayyah.hannan@kcl.ac.uk</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neo</surname>
<given-names>Natsuko</given-names>
</name>
<!--<email>150382ds@tmd.ac.jp</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cash</surname>
<given-names>Alex</given-names>
</name>
<!--<email>alex.cash@gstt.nhs.uk</email>-->
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2265-6727</contrib-id>
<name>
<surname>Li</surname>
<given-names>Dong</given-names>
</name>
<!--<email>lid2@email.chop.edu</email>-->
<xref ref-type="aff" rid="aff12">12</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhoj</surname>
<given-names>Elizabeth</given-names>
</name>
<!--<email>bhoje@email.chop.edu</email>-->
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zackai</surname>
<given-names>Elaine H</given-names>
</name>
<!--<email>zackai@email.chop.edu</email>-->
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cleaver</surname>
<given-names>Ruth</given-names>
</name>
<!--<email>ruth.cleaver@nhs.net</email>-->
<xref ref-type="aff" rid="aff14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baralle</surname>
<given-names>Diana</given-names>
</name>
<!--<email>d.baralle@soton.ac.uk</email>-->
<xref ref-type="aff" rid="aff15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McEntagart</surname>
<given-names>Meriel</given-names>
</name>
<!--<email>Meriel.McEntagart@stgeorges.nhs.uk</email>-->
<xref ref-type="aff" rid="aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Newbury-Ecob</surname>
<given-names>Ruth</given-names>
</name>
<!--<email>ruth.newbury-ecob@uhbristol.nhs.uk</email>-->
<xref ref-type="aff" rid="aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Richard</given-names>
</name>
<!--<email>richardscott3@nhs.net</email>-->
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hurst</surname>
<given-names>Jane A</given-names>
</name>
<!--<email>Jane.Hurst@gosh.nhs.uk</email>-->
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Au</surname>
<given-names>Ping Yee Billie</given-names>
</name>
<!--<email>ping-yee.au@albertahealthservices.ca</email>-->
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hosey</surname>
<given-names>Marie Therese</given-names>
</name>
<!--<email>m.t.hosey@kcl.ac.uk</email>-->
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khokha</surname>
<given-names>Mustafa</given-names>
</name>
<!--<email>mustafa.khokha@yale.edu</email>-->
<xref ref-type="aff" rid="aff7">7</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marciano</surname>
<given-names>Denise K</given-names>
</name>
<!--<email>denise.marciano@utsouthwestern.edu</email>-->
<xref ref-type="aff" rid="aff6">6</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lakhani</surname>
<given-names>Saquib A</given-names>
</name>
<!--<email>saquib.lakhani@yale.edu</email>-->
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="afn1"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2483-2165</contrib-id>
<name>
<surname>Liu</surname>
<given-names>Karen J</given-names>
</name>
<!--<email>karen.liu@kcl.ac.uk</email>-->
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>
<institution>Centre for Craniofacial and Regenerative Biology</institution>, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE1 9RT, UK</aff>
<aff id="aff2"><label>2</label>
<institution>Paediatric Dentistry</institution>, <institution>Centre of Oral</institution>, Clinical and Translational Science, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London SE5 9RS, UK</aff>
<aff id="aff3"><label>3</label>
<institution>Department of Clinical Genetics</institution>, Great Ormond Street Hospital Trust, London WC1N 3JH, UK</aff>
<aff id="aff4"><label>4</label>
<institution>Department of Clinical Genetics</institution>, <institution>Guy’s and St. Thomas’ NHS Foundation Trust</institution>, London SE1 9RT, UK</aff>
<aff id="aff5"><label>5</label>
<institution>Pediatric Genomics Discovery Program</institution>, Department of Pediatrics, <institution>Yale University School of Medicine</institution>, New Haven, CT 06520, <country country="US">USA</country></aff>
<aff id="aff6"><label>6</label>
<institution>Departments of Internal Medicine and Cell Biology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, Dallas, TX 75390-8856, <country country="US">USA</country></aff>
<aff id="aff7"><label>7</label>
<institution>Pediatric Genomics Discovery Program</institution>, Departments of Genetics and Pediatrics, <institution>Yale University School of Medicine</institution>, New Haven, CT 06520, <country country="US">USA</country></aff>
<aff id="aff8"><label>8</label>
<institution>South Thames Cleft Service</institution>, <institution>Guy’s and St. Thomas’ NHS Foundation Trust</institution>, London SE1 7EH, UK</aff>
<aff id="aff9"><label>9</label>
<institution>Department of Medical Genetics</institution>, Cumming School of Medicine, <institution>Alberta Children’s Hospital Research Institute</institution>, University of Calgary, AB, <country country="CA">Canada</country></aff>
<aff id="aff10"><label>10</label>
<institution>Nottingham University Hospitals NHS Trust</institution>, Nottingham NG5 1PB, UK</aff>
<aff id="aff11"><label>11</label>
<institution>Tokyo Medical and Dental University</institution>, Tokyo, <country country="JP">Japan</country></aff>
<aff id="aff12"><label>12</label>
<institution>Center for Applied Genomics</institution>, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, <country country="US">USA</country></aff>
<aff id="aff13"><label>13</label>
<institution>Department of Pediatrics</institution>, Division of Human Genetics, <institution>Children's Hospital of Philadelphia</institution>, Philadelphia, PA 19104, <country country="US">USA</country></aff>
<aff id="aff14"><label>14</label>
<institution>Peninsula Clinical Genetics Service</institution>, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK</aff>
<aff id="aff15"><label>15</label>
<institution>Human Development and Health</institution>, Faculty of Medicine, <institution>University of Southampton</institution>, Southampton SO17 1BJ, UK</aff>
<aff id="aff16"><label>16</label>
<institution>Department of Clinical Genetics</institution>, <institution>St George's Hospital</institution>, London SW17 0RE, UK</aff>
<aff id="aff17"><label>17</label>
<institution>Clinical Genetics</institution>, <institution>University Hospital Bristol NHS Foundation Trust</institution>, Bristol BS2 8EG, UK</aff>
<author-notes>
<corresp id="cor1">To whom correspondence should be addressed. Tel: +44 (0)20 7188 8035; Email: <email>karen.liu@kcl.ac.uk</email></corresp>
<fn id="afn1">
<p>Athina Ververi, Ana Beleza-Meireles, Weizhen Ji, Emily Mis, Quinten T. Patterson, Caitlin A. Chang, Dong Li, Marie Therese Hosey, Mustafa Khokha, Denise K. Marciano and Saquib A. Lakhani contributed equally.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>21</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date iso-8601-date="2020-03-20" pub-type="epub">
<day>20</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>3</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>29</volume>
<issue>11</issue>
<fpage>1900</fpage>
<lpage>1921</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>1</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="ddaa050.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>
<italic>CTNND1</italic> encodes the p120-catenin (p120) protein, which has a wide range of functions, including the maintenance of cell–cell junctions, regulation of the epithelial-mesenchymal transition and transcriptional signalling. Due to advances in next-generation sequencing, <italic>CTNND1</italic> has been implicated in human diseases including cleft palate and blepharocheilodontic (BCD) syndrome albeit only recently. In this study, we identify eight novel protein-truncating variants, six <italic>de novo,</italic> in 13 participants from nine families presenting with craniofacial dysmorphisms including cleft palate and hypodontia, as well as congenital cardiac anomalies, limb dysmorphologies and neurodevelopmental disorders. Using conditional deletions in mice as well as CRISPR/Cas9 approaches to target <italic>CTNND1</italic> in <italic>Xenopus</italic>, we identified a subset of phenotypes that can be linked to p120-catenin in epithelial integrity and turnover, and additional phenotypes that suggest mesenchymal roles of <italic>CTNND1.</italic> We propose that <italic>CTNND1</italic> variants have a wider developmental role than previously described and that variations in this gene underlie not only cleft palate and BCD but may be expanded to a broader velocardiofacial-like syndrome.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Wellcome Trust</institution>
<institution-id institution-id-type="DOI">10.13039/100010269</institution-id>
</institution-wrap>
</funding-source>
<award-id># 099175/Z/12/Z</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Health Innovation Challenge Fund</institution>
</institution-wrap>
</funding-source>
<award-id>HICF-1009-003</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Wellcome Sanger Institute</institution>
</institution-wrap>
</funding-source>
<award-id>WT098051</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>European Xenopus Resource Centre</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Biotechnology and Biological Sciences Research Council</institution>
<institution-id institution-id-type="DOI">10.13039/501100000268</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>British Heart Foundation</institution>
<institution-id institution-id-type="DOI">10.13039/501100000274</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>Medical Research Council</institution>
<institution-id institution-id-type="DOI">10.13039/501100000265</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<institution-wrap>
<institution>NIH</institution>
<institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>DK099478</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="22"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>Introduction</title>
<p>Genetic variation in <italic>CTNND1</italic>, which encodes for the armadillo-repeat protein p120-catenin (p120), is associated with human birth defects, most notably non-syndromic cleft palate and blepharocheilodontic (BCD) syndrome, which involves eyelid, lip and tooth anomalies [MIM: 617681] (<xref ref-type="bibr" rid="ref1">1–3</xref>). In contrast, experiments in animal models have suggested broader developmental roles for <italic>CTNND1</italic>. For example, conditional deletions in mice demonstrate the importance of <italic>CTNND1</italic> for development not only for skin and teeth but also for kidneys and other structures (<xref ref-type="bibr" rid="ref4">4–10</xref>), and the complete deletion of <italic>CTNND1</italic> leads to prenatal lethality (<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref9">9</xref>). Similarly, loss-of-function experiments in <italic>Xenopus</italic> implicate <italic>CTNND1</italic> in craniofacial development (<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>). Here, we describe a series of patients with <italic>CTNND1</italic> variants, all of whom present with multisystem involvement that demonstrates a broad spectrum craniofacial and cardiac syndrome.</p>
<p>p120-catenin is a member of the catenin superfamily of proteins studied in catenin–cadherin interactions; notably, it binds to and stabilizes E-cadherin (<italic>CDH1</italic>) at junctional complexes in epithelia (<xref ref-type="bibr" rid="ref13">13–17</xref>). This binding is via the p120-catenin armadillo repeat domain, and the displacement of p120-catenin from E-cadherin is a key regulatory event at the adherens junction, which results in the endocytosis of E-cadherin and loss of the junction. The protein has a second function as a scaffolding protein for the GTPase RhoA and associated Rho regulatory proteins (<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>). In addition, it can also directly interact with the zinc finger transcriptional repressor Kaiso (ZBTB33), facilitating Wnt signal transduction (<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref>). Thus, p120-catenin appears to be a multi-functional protein, promoting epithelial stability when in complex with E-cadherin and regulating RhoA and transcriptional activities. p120-catenin is also able to associate with mesenchymal cadherins such as N-cadherin and cadherin-11 (<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref22">22</xref>). In mesenchymal cells, p120-catenin associates with non-epithelial cadherins, regulating motility and invasion via cytoskeletal events and transcription. Given its functions in both epithelia and mesenchyme, it is unsurprising that both the loss and gain of p120-catenin have been associated with oncogenesis (<xref ref-type="bibr" rid="ref23">23–25</xref>).</p>
<p>In humans, the <italic>CTNND1</italic> gene is located at 11q11 and consists of 21 exons; of which, exons 11, 18 and 20 are alternatively spliced. Inclusion of exon 11, which is predominantly neural, disrupts a nuclear localization signal, while exon 20 contains a nuclear export signal (<xref ref-type="bibr" rid="ref26">26</xref>). In addition, there are four additional isoforms of the protein, which vary in their transcriptional start sites. Of the four major isoforms, isoform 1 is abundant in mesenchymal cells, while isoform 3 appears preferentially expressed in epithelial cells (<xref ref-type="bibr" rid="ref27">27–30</xref>). The other two isoforms are less well characterized.</p>
<p>The p120 superfamily includes p120-catenin itself, δ-catenin (CTNND2) and ARVCF [armadillo repeat gene deleted in velocardiofacial (VCF) syndrome] all of which can compete for E-cadherin binding. Although it is unclear whether they substitute for one another in other cellular functions (<xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref32">32</xref>), evidence from animal studies suggests some compensatory roles. For instance, δ-catenin (CTNND2) knockdown phenotypes can be rescued with p120-catenin, and the combined depletion of δ-catenin and p120 generates more pronounced effects. However, levels of p120 are not altered by reducing δ-catenin protein levels (<xref ref-type="bibr" rid="ref33">33</xref>). In humans, <italic>CTNND2</italic> variants have been associated with autism spectrum disorders and other neurodevelopmental conditions (<xref ref-type="bibr" rid="ref34">34–39</xref>). Interestingly, the other p120 family member, <italic>ARVCF</italic>, lies in 22q11. While the loss of <italic>TBX1</italic> in 22q11 is thought to cause the key malformations associated with VCF syndrome [MIM: 192430], evidence from animal models suggests that <italic>ARVCF</italic> may also play a role in craniofacial development (<xref ref-type="bibr" rid="ref40">40–43</xref>).</p>
<p>Here, we present a multi-system condition beyond that described in known p120-associated cases, which was recently described in the context of BCD (<xref ref-type="bibr" rid="ref1">1–3</xref>). However, the majority of reported BCD cases are caused by E-cadherin variation (<xref ref-type="bibr" rid="ref1">1–3</xref>). While our subjects possess palatal phenotypes and eyelid anomalies, they also consistently display additional features including cardiac, limb and neurodevelopmental anomalies. Only a subset of our participants had eyelid symptoms, and none were diagnosed with BCD prior to genetic analysis. Therefore, we propose that these novel truncating variants in <italic>CTNND1</italic> should be considered to be a phenotypic expansion beyond BCD. Furthermore, we propose that these variants affect both E-cadherin-dependent and -independent functions of p120-catenin and, given the range of phenotypes seen in our cohort, should be considered more broadly to cause a VCF-like syndrome.</p>
</sec>
<sec id="sec2">
<title>Subjects and Methods</title>
<sec id="sec3">
<title>Recruitment, consent and sample collection</title>
<p>Participants were recruited from one of following: South Thames Cleft Unit at Guy’s and St Thomas Trust (GSTT), London, UK; theUniversity of Calgary, Alberta Children’s Hospital, Canada; the Children’s Hospital of Philadelphia, USA; or the Deciphering Developmental Disorders (DDD) Study, UK (<ext-link ext-link-type="uri" xlink:href="http://www.ddduk.org">www.ddduk.org</ext-link>). <italic>CTNND1</italic> data access was specifically collected under DDD Project CAP180, focusing on cranial neural crest anomalies (ABM/KJL). All individual study protocols were approved by local Institutional Review Boards, including UK Ethics: GSTT (REC16/NI/0026, Northern Ireland REC) and DDD (10/H0305/83, Cambridge South REC, and GEN/284/12, Republic of Ireland REC).</p>
<p>Medical and dental histories were taken, as well as detailed phenotyping by clinical geneticists with expertise in dysmorphology. Saliva for DNA extraction was collected from family trios using the Oragene® DNA (OG-500) kit. All patients also underwent high-resolution analysis for copy number abnormalities using array-based comparative genomic hybridization. Informed consent from all participants was obtained for the publication of data and photographs in the medical literature. All families were offered genetic counseling.</p>
</sec>
<sec id="sec4">
<title>Whole exome sequencing and variant screening</title>
<p>Whole exome sequencing (WES) from trios was performed to identify gene variants. For patients recruited from DDD (<xref ref-type="bibr" rid="ref44">44</xref>), genomic DNA samples from trios were analysed at the Wellcome Trust Sanger Institute. WES was performed using a custom Agilent SureSelect Exome bait design (Agilent Human All Exon V3 Plus with custom ELID # C0338371), 8-plex sample multiplexing and an Illumina HiSeq with four samples per lane and a mean depth of 50X. The exome analysis targeted 58.62 Mb of which 51.64 Mb consisted of exonic targets (39 Mb) and their flanking regions and 6.9 Mb consisted of regulatory regions. Alignment was performed using BWA1. Putative <italic>de novo</italic> variants were identified from trio BAM files using DeNovoGear5. Variants were annotated with the most severe consequence predicted by Ensembl Variant Effect Predictor (VEP version 2.6), and minor allele frequencies from a combination of the 1000 Genomes project (<ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org">www.1000genomes.org</ext-link>), UK10K (<ext-link ext-link-type="uri" xlink:href="http://www.uk10k.org">www.uk10k.org</ext-link>), the NHLBI Exome Sequencing Project (<ext-link ext-link-type="uri" xlink:href="http://esp.gs.washington.edu">esp.gs.washington.edu</ext-link>), Scottish Family Health Study (<ext-link ext-link-type="uri" xlink:href="http://www.generationscotland.org">www.generationscotland.org</ext-link>), UK Blood Service and unaffected DDD parents. All flagged variants were automatically annotated with pathogenicity scores from two variant prioritization algorithms (SIFT23 and PolyPhen24) and compared against the public Human Gene Mutation Database and the Leiden Open Variation Database. For selected probands, WES performed at the Yale Center for Genomic Analysis used genomic DNA isolated from saliva from the probands and their parents. The exons and their flanking regions of the genome were captured using IDT xGen exome capture kit followed by Illumina DNA sequencing (HiSeq 4000). Paired end sequence reads were converted to FASTQ format and were aligned to the reference human genome (hg19). GATK best practices were applied to identify genetic variants, and variants were annotated by ANNOVAR. Probands and parents were sequenced to a mean depth of 93–123 independent reads per targeted base across all the samples. In an average of 94.0% of targeted bases in all of the samples, the coverage was greater than 20X independent reads. Trio WES analysis on variants with allele frequency of less than 1% was carried out to identify <italic>de novo</italic> variants that are absent from the parents. Putative disease-causing variants were validated using whole genome amplified DNA, PCR and capillary sequencing.</p>
</sec>
<sec id="sec5">
<title>Mouse and <italic>Xenopus</italic> husbandry</title>
<p>Animal work was performed in accordance with UK Home Office Project License P8D5E2773 at King’s College London (KJL), University of Texas Southwestern Medical Center Institutional Animal Care and Use Committee protocols (DKM), the European <italic>Xenopus</italic> Resource Centre, Portsmouth UK, or the Yale University Institutional Animal Care and Use Committee protocols (MKK). Mice were genotyped according to standard procedures. Gestational ages for mice were determined by the observation of vaginal plugs, which was considered embryonic day 0.5 (E0.5) and further staging of animals according to Kaufman (<xref ref-type="bibr" rid="ref45">45</xref>). The following mouse strains were used: <italic>Ctnnd1<sup>fl/fl</sup></italic> (MGI ID: 3640772) (<xref ref-type="bibr" rid="ref8">8</xref>); <italic>β-actin::cre</italic> (JAX strain 019099) (<xref ref-type="bibr" rid="ref46">46</xref>) and <italic>Wnt1::cre</italic> (JAX strain 022501) (<xref ref-type="bibr" rid="ref47">47</xref>)<italic>.</italic> For each mouse experiment, a minimum of <italic>n</italic> = 3 was examined unless otherwise noted. <italic>Xenopus tropicalis</italic> embryos were produced by <italic>in vitro</italic> fertilization and raised to appropriate stages in 1/9MR + gentamycin as per standard protocols (<xref ref-type="bibr" rid="ref48">48</xref>). For <italic>Xenopus</italic> experiments, experimental numbers are stated in figures, with a minimum of <italic>n</italic> = 30 in all experimental conditions.</p>
</sec>
<sec id="sec6">
<title>Human specimens</title>
<p>Human embryonic and fetal material was provided by the Joint MRC/Wellcome Trust (Grant #099175/Z/12/Z) Human Developmental Biology Resource (HDBR, <ext-link ext-link-type="uri" xlink:href="http://www.hdbr.org">http://www.hdbr.org</ext-link>) as whole embryos [Carnegie stage 13 (C13, day 28–32)] or sectioned embryos [Carnegie stage 21 (C21, day 50–52)].</p>
</sec>
<sec id="sec7">
<title>Generation of <italic>CTNND1</italic> probe and mRNA <italic>in situ</italic> hybridization</title>
<p>A human <italic>CTNND1</italic> clone was identified from the Human ORFeome Collaboration (<xref ref-type="bibr" rid="ref49">49</xref>) (clone HsCD00513511), encoding <italic>CTNND1</italic> isoform 4, including the entirety of the armadillo repeats and the C-terminal domain. Probes made from this clone should recognize all four <italic>CTNND1</italic> transcripts. Digoxigenin-labeled antisense mRNA probes were produced by linearizing human <italic>CTNND1</italic> clones using BamH1 restriction enzyme, which produces a probe size of ~ 900 base pairs, and <italic>in vitro</italic> transcription with the T7 High Yield RNA Synthesis Kit (E2040S) from New England Biolabs. <italic>In situ</italic> hybridization of mRNA on whole mount and paraffin embedded tissue sections was carried out as per standard protocols (<xref ref-type="bibr" rid="ref50">50</xref>), using an anti-digoxigenin-alkaline phosphatase coupled antibody.</p>
</sec>
<sec id="sec8">
<title>Immunofluorescent antibodies and staining</title>
<p>For immunostaining, mouse embryos at the indicated stages were fixed and processed according to standard protocols. Antigen retrieval was carried out in Tris-EDTA (pH 9) in a 90°C water-bath for 30 min. Primary antibodies used were: phospho-tyrosine p120-catenin clone 2B12, mouse mAb (1:150, Biolegend, Cat. No. 828301); delta 1 Catenin/CAS (phospho S-268) antibody [EPR2380], rabbit mAB (1:150, Abcam, Cat. No. ab79545); E-Cadherin [M168], mouse mAB (1:150, Abcam, Cat. No. ab76055); anti-E-cadherin (24E10), rabbit mAb (1:250, Cell Signaling Technology, Cat. No. 3195); rabbit anti-Pax2 Antibody (1:100, ThermoFisher Scientific, Cat. No. 71-6000) and mouse anti-Collagen Type II, clone 6B3 (1:50, MERCK, Cat. No. MAB8887). Secondary antibodies used were: Alexa Fluor® 488 (Invitrogen, A-11008), Alexa Fluor® 488 (Invitrogen, A-21204), Alexa Fluor® 546 (Invitrogen, A-11060), Alexa Fluor® 568 (Invitrogen, A-11011), Alexa Fluor® 594 (Invitrogen, A-21207) and Alexa Fluor® 647 (Invitrogen, A-21235). All were diluted to 1:400 in phosphate-buffered saline (PBS) containing 0.5% Triton® X-100 (Sigma-Aldrich) and 1% bovine serum albumin. Slides were mounted in Fluoroshield Mounting Medium with DAPI (Abcam, ab104139) and cover slipped. <italic>Xenopus</italic> whole mount embryos and tadpoles were incubated with Hoechst (1:5000 of 20 mg/ml, diluted in PBST). For hematoxylin and eosin (H&amp;E) staining, slides were fixed, sectioned and stained according to standard protocols. Slides were then cover slipped with Neo-Mount (VWR, Cat. No. 1.09016.0500).</p>
</sec>
<sec id="sec9">
<title>Image acquisition</title>
<p>Images for sectional <italic>in situ</italic> hybridization experiments and for H&amp;E slides were captured using a brightfield microscope (Nikon ECLIPSE Ci-L), with an attached camera (Nikon digital sight DS-Fi1) or with a NanoZoomer 2.ORS Digital Slide Scanner (Hamamatsu); NDP.view2 Viewing Software (U12388-01) was used to analyze the scanned images. Whole mount images of mouse pups and embryos, <italic>Xenopus</italic> and human embryos were captured using a Nikon SMZ1500 stereomicroscope with a Nikon digital sight DS-Fi1 (112031) camera. Fluorescent images of mouse palates and <italic>Xenopus</italic> epithelial cells were either acquired on a Leica SP5 confocal or Nikon A1R point scanning confocal; z-stacks of whole mount <italic>Xenopus</italic> tadpoles were captured by mounting the tadpoles on a Cellview Cell Glass Bottom Culture Dish (PS, 35/10 mm, CELLview™, Cat. No. 627860) in PBS. Image sequences were processed using the FIJI (Image J) analysis software.</p>
</sec>
<sec id="sec10">
<title>Micro-computed tomography</title>
<p>For soft tissue scanning, mouse embryos were stained with a near isotonic 1% I2 and 2% potassium iodine solution for 3 days and scanned to produce 6 μm voxel size volumes, using X-ray settings of 90 kVp, 66 uA and a 0.5 mm aluminium filter to attenuate harder X-rays. Camera binning was used to improve signal-to-noise ratios. For hard tissue staining, perinatal mice were scanned to produce 7.4 μm voxel size volumes using X-ray settings of 70 kVp, 114 uA and a 0.5 mm aluminium filter to attenuate harder X-rays. The specimens were analysed using Parallax Microview software package (Parallax Innovations Inc., Ilderton, ON, Canada). Specimens were scanned using a Scanco μCT50 microcomputed tomographic (μCT) scanner (Scanco, Brüttisellen, Switzerland). The specimens were immobilised in appropriately sized scanning tubes using cotton gauze.</p>
</sec>
<sec id="sec11">
<title>CRISPR/Cas9 knockouts in <italic>X. tropicalis</italic></title>
<p>The following non-overlapping single guide RNAs (sgRNAs) were designed to target <italic>X. tropicalis ctnnd1</italic>: sgRNA1—CTAGCtaatacgactcactataGGAACGGGTGTGGGAGCCATgttttagagctagaa and sgRNA2—CTAGCtaatacgactcactataGGGGTGGTATCCCACGCAAGgttttagagctagaa. sgRNA1 targets exon 3 and is thus predicted to disrupt isoform 1 only, while sgRNA2 targets exon 7 and is thus predicted to disrupt all four isoforms. Embryos were injected at the one- or two-cell stage and raised until indicated stages. For CRISPR/Cas9 experiments, statistical significance was defined as <italic>P</italic> &lt; 0.05 and analysed by chi-squared test or Fisher’s exact test.</p>
<fig id="f1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Pedigrees and identification of CTNND1 variants. (<bold>A</bold>) Pedigrees of individuals with identified variants. Family identifications, in brackets [A-I], and patient identification numbers correlate with <xref ref-type="table" rid="TB1">Table 1</xref>. Filled boxes indicate affected individuals demonstrating collective phenotypes described in our cohort. A blank box with a vertical black line indicates an asymptomatic carrier (clinically unaffected). A box with an oblique line indicates a deceased individual. Lightly shaded boxes indicate individuals affected with one or more of the conditions described. (<bold>B</bold>) Schematic representation of the human p120-catenin protein structure and its domains. The variants described in our cohort are shown above the protein with a dark gray arrow. The light gray arrow with the (p.Arg315Cys) variant indicates the other <italic>CTNND1</italic> mutation found in Patient 3 which was inherited from the unaffected father [A]. Arrows in blue, pink and brown represent the variants and their locations reported in Ghoumid <italic>et al</italic>. (<xref ref-type="bibr" rid="ref2">2</xref>), Kievit <italic>et al</italic>. (<xref ref-type="bibr" rid="ref1">1</xref>) and Cox <italic>et al</italic>. (<xref ref-type="bibr" rid="ref3">3</xref>), respectively.</p>
</caption>
<graphic xlink:href="ddaa050f1"></graphic>
</fig>
</sec>
</sec>
<sec id="sec12">
<title>Results</title>
<sec id="sec13">
<title>Identification of <italic>CTNND1</italic> variants</title>
<p>Here, we identify 13 individuals from nine families with novel protein-truncating variants in <italic>CTNND1</italic>. These mutations were not previously described in BCD, orofacial cleft cases nor in gnomAD (<xref ref-type="table" rid="TB1">Table 1</xref>). Family trees are shown in <xref ref-type="fig" rid="f1">Figure 1A</xref>, while mutations from this study and from previous studies have been mapped onto a protein schematic (<xref ref-type="fig" rid="f1">Fig. 1B</xref>). Notably, two unrelated individuals had the same novel (p.Arg461<sup>*</sup>) variant we describe here (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Previously, all subjects had undergone an array-based comparative genome hybridization analysis with normal results. A subset of participants had also been referred for other diagnostic tests, including 22q11 deletion, Down syndrome, CHARGE syndrome (<italic>CHD7</italic> sequencing), Noonan syndrome (<italic>PTPN11</italic> sequencing) and other conditions, but with no definitive diagnoses. WES of the nine families revealed eight novel variants in <italic>CTNND1</italic>, including six confirmed to have arisen <italic>de novo</italic> (in eight patients). Two individuals inherited their variant from affected parents, while two other participants inherited a variant from a parent with a mild phenotype (<xref ref-type="fig" rid="f1">Fig. 1A</xref>). These truncating mutations included nonsense, splicing and frameshift variants (<xref ref-type="table" rid="TB1">Table 1</xref>).</p>
<table-wrap id="TB1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>
<italic>CTNND1</italic> variants in index patients</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Family</th>
<th align="left" colspan="1" rowspan="1">Patient</th>
<th align="left" colspan="1" rowspan="1">Mutation: NM_00108558.1</th>
<th align="left" colspan="1" rowspan="1">Protein: NP_001078927.1</th>
<th align="left" colspan="1" rowspan="1">Variant type</th>
<th align="left" colspan="1" rowspan="1">Exon</th>
<th align="left" colspan="1" rowspan="1">Inheritance</th>
<th align="left" colspan="1" rowspan="1">gnomAD</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">c.443_444delTG</td>
<td align="left" colspan="1" rowspan="1">p.Val148Aspfs<sup>*</sup>24</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">c.443_444delTG</td>
<td align="left" colspan="1" rowspan="1">p.Val148Aspfs<sup>*</sup>24</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">Maternally inherited</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">c.943C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg315Cys</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">Paternal, unlikely causal</td>
<td align="left" colspan="1" rowspan="1">2.44 e − 4 8 FE, 39 NFE, 4 A</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">c.1381C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg461<sup>*</sup></td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">c.1381C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg461<sup>*</sup></td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">D</td>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">c.2389C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg797<sup>*</sup></td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">E</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">c.1481_1485del</td>
<td align="left" colspan="1" rowspan="1">p.Leu494Argfs<sup>*</sup>5</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">Not determined</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">c.1481_1485del</td>
<td align="left" colspan="1" rowspan="1">p.Leu494Argfs<sup>*</sup>5</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">Maternally inherited</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">F</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">c.1595del</td>
<td align="left" colspan="1" rowspan="1">p.Gly532Alafs<sup>*</sup>6</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">c.2598_2601dupTGAT</td>
<td align="left" colspan="1" rowspan="1">p.Ser868<sup>*</sup></td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">Paternally inherited</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">c.2598_2601dupTGAT</td>
<td align="left" colspan="1" rowspan="1">p.Ser868<sup>*</sup></td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">Paternally inherited</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">H</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">c.2702-5A&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.?</td>
<td align="left" colspan="1" rowspan="1">Splice site</td>
<td align="left" colspan="1" rowspan="1">18–19</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">I</td>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">c.2737dupC</td>
<td align="left" colspan="1" rowspan="1">p.His913Profs<sup>*</sup>3</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">c.2737dupC</td>
<td align="left" colspan="1" rowspan="1">p.His913Profs<sup>*</sup>3</td>
<td align="left" colspan="1" rowspan="1">Frameshift</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">
<italic>De novo</italic>
</td>
<td align="left" colspan="1" rowspan="1">Novel</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The Human GRCh37 (hg19) Assembly was used to identify transcript positions. The annotations are all based on the NM_001085458 transcript. Asterisk denotes termination codon; FE, Finnish European; NFE, non-Finnish European; A, African.</p>
</table-wrap-foot>
</table-wrap>
<p>
<italic>CTNND1</italic> variants identified could be grouped according to the overall structure of the protein (<xref ref-type="fig" rid="f1">Fig. 1B</xref>). Beginning with the N-terminal regulatory region, one variant falling within this region was identified in a mother (Patient 1) and later confirmed in her affected daughter by targeted sequencing (Patient 2). The mother’s <italic>de novo CTNND1</italic> variant is designated as c.443_444delTG (p.Val148Aspfs<sup>*</sup>24) affecting exon 6.</p>
<p>Four variants fell within the armadillo repeats, which are predicted to be crucial for interactions with E-cadherin. Two unrelated individuals (Patients 3 and 4) from two different families had the same <italic>de novo</italic> mutation in <italic>CTNND1:</italic> c.1381C&gt;T (p.Arg461<sup>*</sup>) (<xref ref-type="fig" rid="f1">Fig. 1A and B</xref>). This variant results in a non-sense substitution and creates a stop codon in exon 7. In addition, Patient 3 had a rare variant in <italic>CTNND1</italic>, inherited paternally c.943C&gt;T (p.Arg315Cys), which is present at a frequency of 2 × 10<sup>–4</sup> in reference populations (<xref ref-type="bibr" rid="ref51">51</xref>). As the parent shares none of the phenotypes with the patient, this second variant is unlikely to be causative. Moreover, a <italic>CTNND1</italic> frameshift variant c.1481_1485del (p.Leu494Argfs<sup>*</sup>5) in exon 8 was identified in a mother and child; both are affected (Patients 6 and 7, respectively); however, the <italic>de novo</italic> status in the mother had not been confirmed. In the same exon, Patient 8 had a <italic>de novo CTNND1</italic> variant designated as c.1594del (p.Gly532Alafs<sup>*</sup>6). Finally, a <italic>de novo</italic> mutation in armadillo 9 was found in Patient 5 designated as c.2389C&gt;T (p.Arg797<sup>*</sup>) on exon 15.</p>
<p>We found three variants affecting the C-terminal domain, which were present in five patients in three families. The variant c.2598_2601dupTGAT (p.Ser868<sup>*</sup>) was paternally inherited in a family with two affected siblings (Patients 9 and 10). Anecdotally, the father is fit and healthy; however, his palate is narrow and high, and his nose is prominent; his <italic>de novo</italic> status has not been confirmed. Patient 11 has a <italic>de novo CTNND1</italic> variant at the splice acceptor site of exon 19 designated as c.2702-5A&gt;G, which is predicted to create a cryptic splice site, leading to a premature termination codon at the start of exon 19. Finally, Patients 12 and 13 are monozygotic twins carrying a <italic>de novo</italic> frameshift variant in <italic>CTNND1</italic>: c.2737dupC (p.His913Profs<sup>*</sup>3).</p>
</sec>
<sec id="sec14">
<title>Clinical presentation of patients with <italic>CTNND1</italic> variants</title>
<p>Clinical phenotypes are summarized in <xref ref-type="table" rid="TB2">Table 2</xref>, and further details can be found in <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>. Also included in <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref> are the summaries of phenotypes seen in previous reports (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>). Photographs from participants show a number of shared craniofacial and oral features (<xref ref-type="fig" rid="f2">Figs 2</xref> and <xref ref-type="fig" rid="f3">3</xref>, respectively) as well as other affected structures [eyes, ears and limbs (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1</xref>)]. Additional features including heart anomalies and neurodevelopmental conditions are noted in <xref ref-type="table" rid="TB2">Table 2</xref> and <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>.</p>
<table-wrap id="TB2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p>Clinical summary of individuals with <italic>CTNND1</italic> variants</p>
</caption>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
<col align="left" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Participants</th>
<th align="left" colspan="1" rowspan="1">1</th>
<th align="left" colspan="1" rowspan="1">2</th>
<th align="left" colspan="1" rowspan="1">3</th>
<th align="left" colspan="1" rowspan="1">4</th>
<th align="left" colspan="1" rowspan="1">5</th>
<th align="left" colspan="1" rowspan="1">6</th>
<th align="left" colspan="1" rowspan="1">7</th>
<th align="left" colspan="1" rowspan="1">8</th>
<th align="left" colspan="1" rowspan="1">9</th>
<th align="left" colspan="1" rowspan="1">10</th>
<th align="left" colspan="1" rowspan="1">11</th>
<th align="left" colspan="1" rowspan="1">12</th>
<th align="left" colspan="1" rowspan="1">13</th>
<th align="left" colspan="1" rowspan="1">Total</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Variant</th>
<th align="left" colspan="1" rowspan="1">V148Dfs<sup>*</sup>24</th>
<th align="left" colspan="1" rowspan="1">V148D<sup>*</sup>24</th>
<th align="left" colspan="1" rowspan="1">R461<sup>*</sup></th>
<th align="left" colspan="1" rowspan="1">R461<sup>*</sup></th>
<th align="left" colspan="1" rowspan="1">R797<sup>*</sup></th>
<th align="left" colspan="1" rowspan="1">L494Rfs<sup>*</sup>5</th>
<th align="left" colspan="1" rowspan="1">L494Rfs<sup>*</sup>5</th>
<th align="left" colspan="1" rowspan="1">G531Afs<sup>*</sup>6</th>
<th align="left" colspan="1" rowspan="1">S868<sup>*</sup></th>
<th align="left" colspan="1" rowspan="1">S868<sup>*</sup></th>
<th align="left" colspan="1" rowspan="1">c.2702-5A&gt;G</th>
<th align="left" colspan="1" rowspan="1">H913Pfs<sup>*</sup>3</th>
<th align="left" colspan="1" rowspan="1">H913Pfs<sup>*</sup>3</th>
<th align="left" colspan="1" rowspan="1">−</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Sex</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">F</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">M</th>
<th align="left" colspan="1" rowspan="1">6F/7M</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Craniofacial</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Cleft lip/palate</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-arched palate</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Thin upper lip</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Choanal atresia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">4/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ear anomaly</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">9/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Wide nasal bridge</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">11/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Broad nasal tip</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mid-facial hypoplasia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">9/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mandibular prognathism</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">5/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Brachycephaly</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">3/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Eyes and eyelids</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Narrow, upslanted palpebral fissures</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">9/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hooded eyelids</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Telecanthus</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High arched eyebrows</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Thin lateral eyebrows</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td colspan="1" rowspan="1">8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mild ectropion</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">4/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Distichiasis</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">4/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ankyloblepahron</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">3/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dental anomalies</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hypodontia</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Delayed dentition</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">6/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Abnormal crown form</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">9/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cardiac disease</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> VSd</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="7">Total 6/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> TOF</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ASd or PFO</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> MVS</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PS or COA</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PDA</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hypoplastic aortic arch</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neurodevelopmental</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ASD</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">UI</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">UI</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="5">Total 8/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ADHD</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> DD/LD</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Speech &amp; language delay</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Aggressive behaviour</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Limb anomalies</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Total 9/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hands</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Feet</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">7/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Voice anomalies</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">ND</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">3/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other Skeletal</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="3">Total 5/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Scoliosis</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Short stature</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cancer</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">ovarian dysgerminoma</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">1/13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Other anomalies</td>
<td align="left" colspan="1" rowspan="1">restrictive lung disease</td>
<td align="left" colspan="1" rowspan="1">partial agenesis of corpus callosum</td>
<td align="left" colspan="1" rowspan="1">VPI, early onset puberty, bowel problems</td>
<td align="left" colspan="1" rowspan="1">joint laxity</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">hypothyroid</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">macroglossia</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">cryptorchidism</td>
<td align="left" colspan="1" rowspan="1">coronal hypospadias</td>
<td align="left" colspan="1" rowspan="1">−</td>
<td align="left" colspan="1" rowspan="1">−</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>Abbreviation: UI, under investigation, ND; not determined because of non-availability; VSd, ventricular septal defect; ASd, atrial septal defect; TOF, tetralogy of Fallot; CoA, coarctation of the aorta; MVS, mitral valve stenosis; PDA, patent ductus arteriosus; PFO, patent foramen ovale; ASD, autism spectrum disorder; ADHD, attention deficit hyperactivity disorder; DD, developmental delay; LD, learning difficulty; VPI, velo-pharyngeal insufficiency.</p>
</table-wrap-foot>
</table-wrap>
<fig id="f2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Clinical presentation of individuals with a CTNND1 mutation. Facial photos (frontal and profile) show craniofacial features of patients. Note the narrow up-slanting palpebral fissures in Patients 3, 4 and 7–13; the hooded eyelids in Patients 3, 4 and 8–13; telecanthus in Patients 3, 4 and 9–13; the high arched eyebrows in Patients 1, 2, 6–8 and 11–13 and the thin lateral eyebrows in Patients 1 and 5–11. Patients 1 and 4 had missing eyelashes medially from the inner canthus; Patients 1, 2, 5 and 7 have distichiasis (double row of lashes), and mild ectropion of the lower eyelids was seen in Patients 1, 5 and 6. As evident, no patient shows signs of hair sparsity. Most patients had wide nasal bridges with broad nasal tips, while Patients 1, 2, 8 and 11 were also diagnosed with congenital choanal atresia. Patients 1, 2, 7–9, 11 and 12 showed thin upper lips, and while mid-face hypoplasia was observed, Patients 1, 3, 8, 11 and 13 also had mandibular prognathism. Scars from cleft lip operations are seen in Patients 7 and 9–13. Patient 3 was born with a sub-mucous cleft palate, a bifid uvula and VPI.</p>
</caption>
<graphic xlink:href="ddaa050f2"></graphic>
</fig>
<fig id="f3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Dental manifestations and intra-oral phenotypes of patients with a CTNND1 mutation. (<bold>A</bold>–<bold>D</bold>) A high-arched palate was seen, shown are palates of Patients 1, 2, 3 and 8. (<bold>E</bold>, <bold>F</bold>) Abnormalities in the morphology of the dentition included: fissured incisors in patient 11 (E, black arrowheads) and rotation of the incisors from the normal alignment shown in the non-cleft Patient 1 (F, black arrowhead). (<bold>G</bold>, <bold>H</bold>) Hypodontia (tooth agenesis) was a common phenotype, indicated by the black asterisk. Black arrowheads indicate retained primary teeth. Patient 3 also has a diminutive upper left lateral incisor (G, yellow arrowhead) and wide inter-dental spacing (G′, white arrowheads). (<bold>I</bold>–<bold>L</bold>) Dental orthopantograms (OPGs); missing teeth are indicated by white asterisks; diminutive teeth by yellow, macrodont teeth by magenta and supernumerary teeth by blue arrowheads, respectively. (I) OPG of Patient 8 at age 11 shows eight missing permanent teeth (white asterisks) and shows the eruption of the second permanent molars (white arrowheads) in place of the missing first permanent molars. Also shown are diminutive upper right and left lateral incisors (peg-shaped) (yellow arrowheads) and a macrodont lower left second primary molar (magenta arrowhead). (J) OPG of Patient 11, at the age of 14, shows three missing permanent teeth (white asterisks), an ectopic maxillary left permanent canine and rotated maxillary centrals and left lateral incisors and dilacerated roots of the lower second permanent molars. (K) OPG of Patient 2, taken at 4 years, shows missing teeth including a missing lower left first permanent molar (white asterisks); a reported macrodont upper left primary canine (magenta arrowhead) with an underlying missing successor (white asterisk); a macrodont lower left second primary molar (magenta arrowhead) and a supernumerary tooth (blue arrowhead). (L) OPG for Patient 13, taken at 7.5 years, confirms the absence of the upper left permanent lateral incisor and possibly the lower second permanent premolars.</p>
</caption>
<graphic xlink:href="ddaa050f3"></graphic>
</fig>
<p>Participants shared several distinctive eye features including short, up-slanted palpebral fissures (9/13), hooded eyelids (8/13), telecanthus (7/13), highly arched (8/13) and thin lateral eyebrows (8/13) and other eyelid anomalies such as nasolacrimal obstructions (1/13). These eye anomalies were clear from a young age (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1A</xref>). A subset had ectropion (drooping lower eyelids, 4/13) and distichiasis (double eyelashes, 4/13). Many individuals had wide nasal bridges (11/13) with broad nasal tips (7/13), choanal atresia (4/13), either unilateral or bilateral atresia; malar flattening (mid-face hypoplasia) (9/13); mandibular prognathism (5/13); thin upper lips (7/13) and auricular abnormalities (9/13), particularly low-set ears and overfolded helices (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1B</xref>).</p>
<p>Phenotypes with high penetrance involved oropharyngeal abnormalities including cleft lip and/or palate (CLP) (8/13), high-arched palate (7/13) or a combination of cleft and high-arched palate (<xref ref-type="fig" rid="f3">Fig 3A–D</xref>). A range of cleft sub-types was seen (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). In addition, one participant had velopharyngeal insufficiency (VPI) and a bifid uvula. Of interest, three individuals presented with vocalization defects causing stridor and hoarseness or nasal speech.</p>
<p>Upon dental examination, all subjects were found to have intra-oral anomalies (<xref ref-type="fig" rid="f3">Fig. 3</xref>). In particular, congenital tooth agenesis (hypodontia) was frequently seen, with eight subjects missing between 3 and 12 adult teeth (<xref ref-type="fig" rid="f3">Fig. 3G–L</xref>; <xref ref-type="supplementary-material" rid="sup3">Supplementary Material, Table S2</xref>). Other anomalies included retained primary teeth and delayed eruption of the permanent teeth (6/13) (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). Morphologic tooth anomalies were present, including diminutive permanent teeth/peg-shaped lateral incisors and fissured crowns of the permanent central and lateral incisors (<xref ref-type="fig" rid="f3">Fig. 3E and F</xref>; <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>).</p>
<p>Beyond the craniofacial structures, the majority of the participants had limb and heart anomalies. Mild limb phenotypes (9/13) were present, including shorter fifth fingers, single transverse palmar crease, mild syndactyly between the 2 and 3 toes, sandal gaps and camptodactyly of the toes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1C</xref>). Congenital cardiac defects, which have not previously been associated with <italic>CTNND1</italic> variants, consistently occurred in our cohort. Six subjects had cardiovascular anomalies including tetralogy of Fallot, hypoplastic aortic arch, coarctation of the aorta, ventricular septal defect, atrial septal defect, mitral valve stenosis, patent ductus arteriosus and patent foramen ovale (<xref ref-type="table" rid="TB2">Table 2</xref>; <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). Finally, in addition to the craniofacial and cardiac anomalies, individuals presented with other phenotypes that added to the complexity of their conditions. Developmental delay and other neurodevelopmental problems were also observed (8/13). These often appeared from early toddler and school years and included mild learning difficulties, autism spectrum disorder, speech and language delay and behavioral problems (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). One individual was diagnosed with ovarian dysgerminoma stage III in the left ovary at the age of 12 years, which was treated with left oophorectomy followed by chemotherapy. Other infrequent anomalies included urogenital problems, scoliosis and partial agenesis of the corpus callosum (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>).</p>
</sec>
<sec id="sec15">
<title>
<italic>CTNND1</italic> is expressed during human embryonic development</title>
<p>
<italic>CTNND1</italic> has recently been linked to non-syndromic cleft palate (<xref ref-type="bibr" rid="ref3">3</xref>). In that study, Cox <italic>et al</italic>. (<xref ref-type="bibr" rid="ref3">3</xref>) documented the protein distribution of human p120-catenin protein, focusing on the fusion of the secondary palate. However, to our knowledge, little is known about human <italic>CTNND1</italic> mRNA expression during pharyngeal arch stages. Given the multi-system anomalies seen in our subjects, it was important to examine expression at earlier stages during the development of the cranio-cardiac structures. Therefore, we carried out mRNA <italic>in situ</italic> hybridization on human embryos using a probe that binds to all four C<italic>TNND1</italic> mRNA transcripts.</p>
<p>At Carnegie stage 13 (CS13), we found expression at multiple sites within the developing head, including the frontonasal processes, the forebrain, midbrain and rhombomeres (<xref ref-type="fig" rid="f4">Fig. 4B and C</xref>). Robust expression was also detected in the maxillary and mandibular processes of the first pharyngeal arch (PA1), the second and third pharyngeal arches (PA2 and PA3, respectively) as well as in the proximal domains of the upper and lower limb buds (<xref ref-type="fig" rid="f4">Fig. 4A and B</xref>). Signal was also weakly detected in the somites; however, strong expression was seen in the developing heart, trigeminal ganglion and the 10th cranial nerve (<xref ref-type="fig" rid="f4">Fig. 4A and B</xref>).</p>
<fig id="f4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>P120-catenin is expressed during relevant stages of human embryonic development. <italic>CTNND1</italic> mRNA <italic>in situ</italic> hybridization at human Carnegie stages 13 (CS13) (<bold>A</bold>–<bold>C</bold>) and 21 (<bold>D</bold>–<bold>G</bold>). (A) Right lateral view of a CS13 human embryo, <italic>CTNND1</italic> mRNA is strongly expressed in the head in all three pharyngeal arches (PA1, PA2 and PA3) and limb buds. Expression is specifically strong around the nasal placode and the maxillary and mandibular prominences. (B) Left lateral view, P120 is strongly expressed in the developing heart, frontonasal process, the trigeminal ganglion and the tenth cranial nerve. (C) P120 is ubiquitously expressed in the developing brain region in the rhombomeres, the forebrain and midbrain. (D–G) Coronal section through the head of a CS21 human embryo through a mid-palatal plane. (D) Strong expression is seen in the intrinsic muscles of the tongue: the superior longitudinal (magenta arrowhead), the transversal muscles of the tongue (black arrowhead) and the extrinsic genioglossus muscle (blue arrowhead). (E) <italic>CTNND1</italic> mRNA is strongly expressed in the epithelium of the developing tooth bud. (F) <italic>CTNND1</italic> is expressed on the dorsal epithelium of the palatal shelf (arrowhead) and in the epithelium of the tongue. (G) Expression is seen in the cardiomyocytes of the ventricular wall and the interventricular septum and in the cells of the endocardium (arrowhead). Scale bars = 100 μm. Abbreviations: PA1, first pharyngeal arch; PA2, second pharyngeal arch; PA3, third pharyngeal arch; Tg, trigeminal ganglion; Mx, maxillary process; Md, mandibular process; CN X, tenth cranial nerve; ULB, upper limb bud; S, somites; LLB, lower limb bud; NP, nasal placode; H, heart, FNP, frontonasal process; Tb, mandibular tooth bud; PS, palatal shelf; T, tongue; IVS, interventricular septum; VW, ventricular wall.</p>
</caption>
<graphic xlink:href="ddaa050f4"></graphic>
</fig>
<p>By Carnegie stage 21, <italic>CTNND1</italic> mRNA was expressed in the brain (data not shown), tooth bud (<xref ref-type="fig" rid="f4">Fig. 4E</xref>), the epithelial lining of the tongue and oral cavity and in the tongue mesenchyme (<xref ref-type="fig" rid="f4">Fig. 4D</xref>). Expression was particularly strong in the intrinsic muscles of the tongue: the superior longitudinal and transversal muscles, and in the extrinsic genioglossus muscle (<xref ref-type="fig" rid="f4">Fig. 4D</xref>). Moreover, expression was evident in the dorsal epithelial lining of the developing palatal shelves (<xref ref-type="fig" rid="f4">Fig. 4F</xref>). In the heart, <italic>P120</italic> expression was found in the cardiomyocytes of the ventricular wall and interventricular septum, in addition to strong expression in the endocardium (<xref ref-type="fig" rid="f4">Fig. 4G</xref>). Expression was also found in the intrinsic epithelial lining of the stomach wall; both in the pyloric part of the stomach and in the inner walls of the stomach body, the pancreatic islets, the germinal center of the spleen, the epithelial lining of the bladder, hindgut and in the spinal cord and vertebral body (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S2</xref>).</p>
</sec>
<sec id="sec16">
<title>Expression of phosphorylated p120-catenin predicts fusion of the palatal seam</title>
<p>Because all of our participants had either cleft palate or associated palatal anomalies, we also assessed p120-catenin expression during palatal fusion in the mouse, which occurs from embryonic day 12.5 (E12.5) to E15.5 (<xref ref-type="fig" rid="f5">Fig. 5A–D</xref>). To examine this, we used two antibodies recognizing phosphorylated forms of p120-catenin: a tyrosine-phosphorylated form or phosphorylation at serine 268 (pS-268), which is proposed to trigger the disruption of epithelial cadherin-catenin complexes (<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref>). Neither of these forms of p120-catenin had been previously analyzed in the palate. In palatal cross-sections at E14.5, the medial epithelial seam (MES) is evident (<xref ref-type="fig" rid="f5">Fig. 5B</xref>), followed a few hours later with dissolution of the seam at E14.75 (<xref ref-type="fig" rid="f5">Fig. 5C</xref>). While E-cadherin is expressed as expected in the MES (<xref ref-type="bibr" rid="ref54">54</xref>) (<xref ref-type="fig" rid="f5">Fig. 5F and J</xref>), the two forms of p120-catenin show very distinctive distributions. As the seam undergoes EMT, at E14.5, pS-268 is strongly expressed as predicted in cell–cell interfaces of the periderm layer along the medial seam, clearly co-localising with E-cadherin (<xref ref-type="fig" rid="f5">Fig. 5E and F</xref>). As the seam degrades, E-cadherin expression is lost while p120-catenin expression remains (<xref ref-type="fig" rid="f5">Fig. 5G and H</xref>, white arrowheads). To our surprise, we find phospho-tyrosine p120 staining in both the mesenchymal and the epithelial cells, with a clear enrichment marking the border between the epithelial and mesenchymal populations (<xref ref-type="fig" rid="f5">Fig. 5I and J</xref>, pink arrowheads). This distribution appears unique to this stage of palate formation consistent with reports that p120-catenin is tyrosine phosphorylate in an EGFR-dependent manner (<xref ref-type="bibr" rid="ref55">55</xref>), and continues during the degradation of the seam while E-cadherin expression decreases (<xref ref-type="fig" rid="f5">Fig. 5K and L</xref>, pink arrowheads). As a control, in earlier stages (E11–12.5), the phospho-tyrosine expression is much lower and nearly identical to the pS-268 staining (data not shown).</p>
<fig id="f5" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p>Expression of phosphorylated p120-catenin predicts fusion of the palatal seam. (<bold>A</bold>–<bold>L</bold>) All images are coronal sections of CD1 wild-type murine embryos at consecutive stages of palatal development. (A–D) H&amp;E staining illustrates successive stages of palatogenesis from embryonic day (E) 12.5 to E15.5. (B) At E14.5, following horizontal elevation, the opposing palatal shelves (blue arrows) meet and adhere to form the MES. (C) EMT occurs at E14.75 when the MES breaks down, forming epithelial islands (blue arrowhead); the nasal and oral epithelial triangles form (yellow arrows). (D) At E15.5 palatal shelves are fused. Red box in (B) marks the regions shown in (E, F, I and J). Red box in (C) marks the regions shown in (G, H, K and L). (E–L) Immunofluorescent staining for either pS-268 or p-tyrosine p120-catenin antibodies (green) shown independently in (E, G, I and K), or in a merge with E-cadherin antibody staining (red) and DNA/DAPI stain (blue) (F, H, J and L). (E, F, I and J) At E14.5, both forms of p120-catenin are expressed, with pS-268 strongly expressed in the periderm at the midline seam co-localizing with E-cadherin (E and F), while p-tyrosine clearly enriched in the area marking the border between the epithelial and mesenchymal populations (I, J, pink arrowheads). (G, H, K and L) At E14.75, pS-268 p120-catenin is strongly expressed in the epithelial islands and the oral and nasal epithelial triangles; this is co-localised with E-cadherin during EMT and endocytosis, while p120-catenin expression remains in some areas (H, white arrowheads). In contrast, p-tyrosine p120-catenin expression surrounds E-cadherin positive epithelial islands, while E-cadherin expression has disappeared in the intervening mesenchymal cells (L, pink arrowheads). Scale bars = 50 μm. Abbreviations: T, tongue; PS, palatal shelf.</p>
</caption>
<graphic xlink:href="ddaa050f5"></graphic>
</fig>
</sec>
<sec id="sec17">
<title>Heterozygous loss of p120-catenin leads to structural changes in the laryngeal apparatus</title>
<p>Some of our participants presented with anomalies associated with dysfunction of their velopharyngeal muscles and voice irregularities (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>; <xref ref-type="table" rid="TB2">Table 2</xref>), a phenotype described in patients with VCF syndrome (<xref ref-type="bibr" rid="ref56">56–58</xref>). Antibody staining confirmed the presence of p120-catenin protein during the development of the laryngeal and pharyngeal tissues in the mouse (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3A</xref>). We then examined the laryngeal structures of mutant mice compared with their littermate controls at E16.5, P1 and P2.5 (<xref ref-type="fig" rid="f6">Fig. 6</xref>). To do this, we crossed a mouse carrying the ubiquitous <italic>β-actin::cre</italic> driver with <italic>Ctnnd1<sup>fl/fl</sup></italic> mice in order to generate heterozygous mutants (<xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref60">60</xref>) (<xref ref-type="fig" rid="f6">Fig. 6C, H, M, R</xref>). Because we previously showed that the vocal ligaments (VLs) originated from the neural crest (<xref ref-type="bibr" rid="ref61">61</xref>), we also generated tissue-specific <italic>Ctnnd1</italic> heterozygotes using the neural crest-specific driver, <italic>Wnt1::cre</italic> (<xref ref-type="bibr" rid="ref62">62</xref>) (<xref ref-type="fig" rid="f6">Fig. 6E, J, O</xref>). We found identical laryngeal anomalies in the heterozygous mutants in both mouse crosses, confirming the neural crest-specificity of these phenotypes.</p>
<fig id="f6" orientation="portrait" position="float">
<label>Figure 6</label>
<caption>
<p>Heterozygous loss of p120-catenin leads to structural changes in the laryngeal apparatus. (<bold>A</bold>–<bold>O</bold>) Progression of the pharyngeal and laryngeal anomalies, (A, F and K) Schematics show the organization of the wild-type oropharynx from the more rostral (A) to caudal (K) planes. H&amp;E staining of coronal sections through control (B, G, L: <italic>Ctnnd1<sup>fl/+</sup></italic>) and heterozygous mutants (C, H, M: <italic>β-actin::cre/+; Ctnnd1<sup>fl/+</sup></italic>) littermate at postnatal stage (P1). (B and C) The SPC (blue arrowhead) and PLP (red arrowhead) in mutants are disorganized with an increased thickness in the PLP cranio-caudally (C) as compared with the controls (B). (G and H) The FVC (vestibular folds) are well defined in the controls with abundant ligaments (G, red arrowhead). The FVC are fused in the mutant mice (H, black arrowhead) with ill-defined vestibular ligaments (H, red arrowhead). (L and M) The muscle attachments (blue arrowheads) superior to the FVC (black arrowhead) are well organized bilaterally in the controls surrounding the COC (L). Caudally, when the FVC separated in the mutants, it appeared hypoplastic (black arrowhead) as did the COC. The muscles (blue arrowheads) were ectopically fused to the LVP, producing an appearance of a ‘high-arched’ epiglottal area (M, orange hollow arrowhead). (D, E, I, J, N and O) Neural crest-specific mutants showed comparable laryngeal phenotype. μCT soft tissue scans of E16.5 control (D, I, N: <italic>Ctnnd1<sup>fl/+</sup></italic>) or neural-crest-specific (E, J, O: <italic>Wnt1::cre/+; Ctnnd1<sup>fl/+</sup></italic>) heterozygous mutant littermates. (D and E) Compare the PLP in control (D) to the very thick PLP muscle seen in mutant (E, red arrowheads). Compare the SPC in control (D) to the disorganized and hypoplastic SPC muscles seen in mutants (E, blue arrowheads). (I and J) Laryngeal webbing was observed in mutant TVF (J, yellow arrowhead) compared with parallel TVF in control littermate (I, yellow arrowhead). (N and O) Note aberrant muscle attachments (blue arrowheads) in (O) compared with control (N). Control (N) epiglottal region compared with the high-arched epiglottal area observed in mutant littermate (O, orange hollow arrowhead). (P–S) The laryngeal webbing phenotype. (P and S) Schematic representations of the wild-type (P) and mutant (S) anatomy at the vocal folds (TVF) from yellow-boxed insets in (G) and (H), respectively. (Q and R) H&amp;E staining of coronal sections through control (Q: <italic>Ctnnd1<sup>fl/+</sup></italic>) and heterozygous mutant (R: <italic>β-actin::cre/+;Ctnnd1<sup>fl/+</sup></italic>) littermate at P1. (Q) In controls, well-defined VLs run parallel to the true vocal fold/cords (TVF). Underlying, the vocalis muscle (VM) and the thyroarytenoid muscle (TAM) are clearly attached and well-organised. (R) Laryngeal webbing is seen in the heterozygous mutant mice, where the VLs accumulate at a thin contact point (black arrowhead), thus perturbing the correct muscle attachments of the VM and TAM. Scale bars = 100 μm. Abbreviations: PLP, palatopharyngeus muscle; TAM, thyroarytenoid muscle; VM, vocalis muscle; HB, hyoid bone; Epi, epiglottis; OB, occipital bone; LVP, levator veli palatini muscle; AEF, aryepiglottic fold; FVC, false vocal cord; CC, cricoid cartilage; TC, thyroid cartilage; AC, arytenoid cartilage.</p>
</caption>
<graphic xlink:href="ddaa050f6"></graphic>
</fig>
<p>Specifically, in control <italic>Ctnnd1<sup>fl/+</sup></italic> mice, the palatopharyngeus (PLP) muscle, which elevates the larynx, is well defined and runs uniformly perpendicular to the epiglottis thereby attaching to the superior pharyngeal constrictor (SPC) muscle on either side (<xref ref-type="fig" rid="f6">Fig. 6A, B and D</xref>). On the other hand, the PLP and the SPC were both severely disorganized in both sets of heterozygous mice with an apparent increase in the cranio-caudal thickness of the PLP muscle (<xref ref-type="fig" rid="f6">Fig. 6C and E</xref>). Second, a striking phenotype known as laryngeal webbing was observed (compare controls, <xref ref-type="fig" rid="f6">Fig. 6G, I, and Q</xref>, to mutants <xref ref-type="fig" rid="f6">Fig. 6H, J, and R</xref>). Typically, the bilateral vocal cords are parallel and meet at the midline (<xref ref-type="fig" rid="f6">Fig. 6F–G</xref>, with inset schematized and shown in <xref ref-type="fig" rid="f6">Fig. 6P and Q</xref>). The outer layer of the vocal fold is made of an epithelium that encapsulates the lamina propria comprising the VLs (<xref ref-type="fig" rid="f6">Fig. 6P and Q</xref>). These two layers function as the vibratory components for phonation and oscillation. Instead, in heterozygous mutant mice, the VLs show only a brief contact point between the opposing epithelia (<xref ref-type="fig" rid="f6">Fig. 6H</xref>, with inset schematized and shown in 6R and 6S). The vocal cords are also thinner, lacking the lamina propria (<xref ref-type="fig" rid="f6">Fig. 6R</xref>). Laryngeal webbing was also seen in the <italic>Wnt1::cre</italic> heterozygotes (<xref ref-type="fig" rid="f6">Fig. 6J</xref>) compared with their littermate controls (<xref ref-type="fig" rid="f6">Fig. 6I</xref>).</p>
<p>While the vestibular folds were well demarcated and the ligaments within them clearly defined in controls (<xref ref-type="fig" rid="f6">Fig. 6G</xref>), the vestibular folds in the heterozygous mice were ectopically fused and the ligaments sparse and dispersed (<xref ref-type="fig" rid="f6">Fig. 6H</xref>). Caudally, where the vestibular folds surrounded the normal corniculate cartilage (COC) (<xref ref-type="fig" rid="f6">Fig. 6K and L</xref>), the folds have separated in the <italic>Ctnnd1</italic> heterozygotes, albeit hypoplastic (<xref ref-type="fig" rid="f6">Fig. 6M</xref>). Similarly, the COC appeared hypoplastic and devoid of the underlying lamina propria (<xref ref-type="fig" rid="f6">Fig. 6M</xref>). Finally, in mutants, the muscles were ectopically fused to the levator veli palatini muscles, which were then fused to the cranial base (<xref ref-type="fig" rid="f6">Fig. 6M</xref>). This, in turn, gave the impression of a high-arched epiglottal area; a defect also found in the <italic>Wnt1::cre</italic> heterozygous mutants (<xref ref-type="fig" rid="f6">Fig. 6O</xref>).</p>
<p>We also explored other craniofacial phenotypes in our heterozygous mouse model. Compared with their littermate controls (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3B, a–e</xref>), mutant mice did not show any cleft lip (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3B, f</xref>), face or limb dysmorphologies (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3B, f–h</xref>) or cleft palate (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3B, i</xref>) (<italic>n</italic> = 12), consistent with previous findings by Cox <italic>et al.</italic> This was confirmed by micro-computed tomography (μCT) to check for associated bony defects (<italic>n</italic> = 6) (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S3B, j</xref>).</p>
</sec>
<sec id="sec18">
<title>P120-catenin isoform 1 function is required in multiple organ systems</title>
<p>While the genetic mutation of <italic>p120-catenin</italic> in mouse models revealed a role for the neural crest in oropharyngeal development, analysis of multi-system involvement of p120-catenin was difficult due to the embryonic lethality of the homozygous null mice (<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref9">9</xref>). We therefore turned to the frog <italic>Xenopus</italic>, where <italic>in vivo</italic> function of p120-catenin has been well studied (<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref63">63</xref>). Previous analyses of p120-catenin requirements were mainly performed with antisense morpholino oligonucleotide knockdowns, which transiently prevent protein translation (<xref ref-type="bibr" rid="ref11">11</xref>). Instead, to create genetic mutants, we used CRISPR<italic>/</italic>Cas9 approaches, allowing us to specifically delete different p120-catenin isoforms (<xref ref-type="bibr" rid="ref64">64</xref>). As noted in the introduction, isoform 1 [full length at 968 amino acids (aa)] is most abundant in mesenchymal cells, while isoform 3 (start at aa 102) is preferentially expressed in epithelial cells (<xref ref-type="bibr" rid="ref27">27–30</xref>). Isoforms 2 and 4, which start at 55 aa and 324 aa, respectively, are less well characterized.</p>
<p>Embryos were injected at the one-cell stage with sgRNAs targeting either of two coding exons, exon 3 or exon 7 (sgRNA1 and sgRNA2 respectively, <xref ref-type="fig" rid="f7">Fig. 7A</xref>). Disruptions in exon 3 are predicted to only affect isoform 1, while sgRNA2 targeting exon 7 disrupts all four isoforms.</p>
<fig id="f7" orientation="portrait" position="float">
<label>Figure 7</label>
<caption>
<p>
<italic>Ctnnd1</italic> knockouts in <italic>Xenopus</italic> give rise to craniofacial and heart defects. (<bold>A</bold>) Embryos were injected at the one-cell stage with sgRNAs, sgRNA1 and sgRNA2 targeting exons 3 and 7, respectively. (<bold>B</bold>) Ventral view showing blastopores at stage 11. Embryos injected with sgRNA1 had delayed blastopore closure (bottom row) compared to un-injected controls (UIC) (top row). The bar chart shows quantitation. Scale bars = 100 μm. (<bold>C</bold>) Confocal sections through the apical surface of ectodermal cells at stage 11 of embryos injected with sgRNA1 (e–h) and UICs (a–d). (C) (a–d) p120-catenin (a, green) is expressed in puncta at the cell membranes. E-cadherin (b, red) is expressed more evenly through the cell membranes. Both are colocalized at the cell–cell interface (c, d). Endogenous levels of p120-catenin and E-cadherin are diminished at the cell–cell interface in the sgRNA1-injected embryos (e, f). Residual p120-catenin and E-cadherin are seen in a spot-like pattern, only at the tricellular junctions (e–h, white arrowheads). (<bold>D</bold>) p120-catenin depletion led to lethality in embryos by the neurula stage. (<bold>E</bold>) Stage 46 tadpoles. (E) (i, l) Lateral views show a flattened profile in <italic>p120</italic> CRISPR tadpoles (l) compared with UICs (i). (E) (j, m) Frontal views showing a reduction in the size of mouth opening and a persistent cement gland (white arrowhead) in <italic>p120</italic> CRISPR tadpoles (m) compared with UICs (j). (E) (k, n) Ventral views showing a reduction in the size of craniofacial cartilages, altered cardiac looping (black-dashed outline) and altered gut coiling (yellow arrowhead) in <italic>p120</italic> CRISPR tadpoles (n) compared to UICs (k). Quantification of craniofacial defects in UIC and p120 depleted tadpoles. Scale bars = 100 μm. <sup>****</sup><italic>P</italic> &lt; 0.0001; <sup>***</sup><italic>P</italic> &lt; 0.001.</p>
</caption>
<graphic xlink:href="ddaa050f7"></graphic>
</fig>
<p>When embryos were scored at gastrula stages following sgRNA1 injections, disrupted or delayed blastopore closure was evident (<italic>n</italic> = 30/42 versus 2/30 in the controls) (<xref ref-type="fig" rid="f7">Fig. 7B</xref>). Furthermore, we noted severe early lethality (<xref ref-type="fig" rid="f7">Fig. 7D</xref>), especially using sgRNA2 which blocked all isoforms (<xref ref-type="fig" rid="f7">Fig. 7D</xref>). Notably, by neurula stages, the majority of these mutants died due to a loss of integrity in the epithelium (data not shown).</p>
<p>Since the most well-established epithelial role for p120-catenin is in complex with E-cadherin at cell–cell junctions, we first examined E-cadherin localization in the neurectoderm at stage 11, as gastrulation was concluding. Indeed, in uninjected controls, high levels of p120-catenin and E-cadherin were found co-localized at the cell interface (<xref ref-type="fig" rid="f7">Fig. 7C, a–d</xref>). E-cadherin is expressed throughout the cell membrane (<xref ref-type="fig" rid="f7">Fig. 7C, b</xref>), whereas p120-catenin, though localized to the cell membrane, appears distributed in puncta (<xref ref-type="fig" rid="f7">Fig. 7C, a</xref>). Upon p120-catenin deletion, the expression levels of endogenous E-cadherin in the epithelial cells were diminished particularly at the interface between the cells, leaving only the spot-like localization of both proteins at the tricellular junctions of these epithelial cells (<xref ref-type="fig" rid="f7">Fig. 7C, e–h</xref>). The residual expression of p120-catenin may be due to the maternal loading of the protein, as the CRISPRs should only affect zygotic transcription, or due to the mosaicism of the CRISPR deletion.</p>
<p>As the sgRNA2 CRISPR was predicted to disrupt all four isoforms and led to severe lethality by neurula stages, the majority of analyses were performed using the sgRNA1 CRISPR, which is predicted to disrupt the predominantly mesenchymal isoform 1. A proportion of the knockout animals survived past the neurula stages, possibly due to mosaicism, and were examined at stage 46 to determine whether craniofacial and organ development had occurred normally. We observed obvious craniofacial defects in the CRISPR mutants, including a reduction in the width and height of the head (<xref ref-type="fig" rid="f7">Fig. 7E, l–n</xref>), a hypoplastic mouth opening (<xref ref-type="fig" rid="f7">Fig. 7E, m</xref>), delayed breakdown of the cement gland (<xref ref-type="fig" rid="f7">Fig. 7E, l, m</xref>) and heart and gut looping anomalies (<xref ref-type="fig" rid="f7">Fig. 7E, n</xref>). Following on from the disorganization of the laryngeal muscles seen in the mouse mutants (<xref ref-type="fig" rid="f6">Fig. 6</xref>), antibody staining against Pax2 was used to label the muscle fibers while anti-collagen 2 (col2) antibody labelled craniofacial cartilages in the mutants (<xref ref-type="fig" rid="f8">Fig. 8A, a–h</xref>). In control animals, the muscle fibers were well organised and straight, while in the mutants, the muscle morphology appeared disorganized, particularly the rectus abdominus muscle, with muscle striations being replaced by irregularly shaped fibers (<xref ref-type="fig" rid="f8">Fig. 8A, f, g</xref>). Consistent with previous observations (<xref ref-type="fig" rid="f7">Fig. 7</xref>), craniofacial cartilages were hypomorphic and compacted both in the anterior-posterior and dorsal-ventral axes (Fig. 8A, a and e). However, morphology of the chondrocytes appeared normal (<xref ref-type="fig" rid="f8">Fig. 8A, d, h</xref>).</p>
<fig id="f8" orientation="portrait" position="float">
<label>Figure 8</label>
<caption>
<p>
<italic>Ctnnd1</italic> knockouts in <italic>Xenopus</italic> give rise to altered morphogenesis of the muscles and heart. (<bold>A</bold>) Immunofluorescent staining for collagen 2 (col2, magenta), muscle/pax2 (white) and nuclei (DAPI, blue); (a, anterior; p, posterior; d, dorsal; v, ventral). (A) (a, e) A lateral view of col2-positive branchial cartilages in UIC (a) and <italic>p120</italic> CRISPR mutant (e) reveals the hypoplasia of mutant cartilages; however, cell morphology appears normal in <italic>p120</italic> CRISPR mutants (h) (d and h, white arrowheads). (A) (b, c, f and g) Pax2-expressing muscles revealed a defect in the fibril organization of the rectus abdominus muscle in the <italic>p120</italic> CRISPR tadpoles (f, white arrowhead) compared with the UIC muscles (b, white arrowhead); note insets in (c, g). (<bold>B</bold>) Ventral views of hearts of stage 46 tadpoles. Immunofluorescent staining for p120-catenin (green), E-cadherin (red) and DNA (blue). (B) (i–m) Controls; (n–r) <italic>p120</italic> CRISPR mutant tadpoles. Morphologic defects are evident in the size of the heart and directionality of the loops (compare control heart (i) to mutant heart (n), yellow-dashed outlines). (B) (k, p) p120-catenin is strongly expressed in the heart of UIC tadpoles (k) but is lost in <italic>p120</italic> CRISPR tadpoles (p). (B) (l, q) Note the absence of E-cadherin in the control and mutant hearts. Scale bars = 100 μm.</p>
</caption>
<graphic xlink:href="ddaa050f8"></graphic>
</fig>
<p>Finally, since the participants (6/13) had a high frequency of congenital heart defects and because p120 is strongly expressed in the heart of human, mouse and frog embryos, we examined the hearts in the CRISPR-knockout tadpoles. Notably, the strong expression of p120 seen in the different heart chambers in the control tadpoles was lost when p120 was knocked down (<xref ref-type="fig" rid="f8">Fig. 8B, p</xref>). The majority of mutant tadpoles had heart anomalies including heart-looping defects (<xref ref-type="fig" rid="f7">Figs 7E, n and </xref><xref ref-type="fig" rid="f8">8B, n</xref>). Notably, E-cadherin is not expressed in the normal heart or the muscles (<xref ref-type="fig" rid="f8">Fig. 8B, I</xref>), suggesting that the heart and muscle phenotypes may be manifestations of E-cadherin independent functions of p120.</p>
</sec>
</sec>
<sec id="sec19">
<title>Discussion</title>
<p>This work expands upon the spectrum of abnormalities associated with <italic>CTNND1</italic> variants beyond non-syndromic CLP and BCD (<xref ref-type="bibr" rid="ref1">1–3</xref>). Most notably, we describe in detail characteristic craniofacial features including choanal atresia and unusual patterns of hypodontia as well as heart, limb, laryngeal and neurodevelopmental anomalies. We find the expression of <italic>CTNND1</italic> mRNA during the development of the pharyngeal arches in human embryos, and we define the profile of two phosphorylated forms of p120 in the mouse palate. Finally, genetic approaches in mouse and <italic>Xenopus</italic> demonstrated novel roles for <italic>CTNND1</italic> in the oropharynx, craniofacial cartilages and in the heart. Thus, our data implicate <italic>CTNND1</italic> variants as causative of a broad-spectrum syndrome that overlaps with DiGeorge VCF syndrome as well as other disorders of craniofacial development such as CHARGE and Burn McKeown syndromes (<xref ref-type="bibr" rid="ref65">65–68</xref>). All of these syndromes could be collectively considered to be neurocristopathies. Notably, the neural crest-specific disruption of <italic>CTNND1</italic> in our animal models supports this role for <italic>CTNND1</italic> as a candidate neurocristopathy gene, and we suggest that these newly identified variants likely highlight both epithelial and mesenchymal roles for p120-catenin.</p>
<p>Prior to our study, the majority of the participants did not have a recognizable or a diagnosed condition when they were recruited. Here, we demonstrate that they collectively share consistent characteristic phenotypic features that suggest that mutations in <italic>CTNND1</italic> may lead to a much broader phenotypic spectrum than previously described (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>). For instance, low set ears were reported in one case of BCD by Kievit and colleagues (<xref ref-type="bibr" rid="ref1">1</xref>); we find multiple participants with auricular anomalies particularly the low-set ears and over-folded helices (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1B</xref>; <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). Similarly, syndactyly was reported in one of the <italic>CTNND1</italic> patients described in Ghoumid <italic>et al</italic>. (<xref ref-type="bibr" rid="ref2">2</xref>), and clinodactyly (one patient) and camptodactyly (two patients) were reported by Kievit <italic>et al</italic>. (<xref ref-type="bibr" rid="ref1">1</xref>). Again, we find limb anomalies consistently associated with <italic>CTNND1</italic> variation (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1C</xref>; <xref ref-type="supplementary-material" rid="sup2">Supplementary Material</xref>, <xref ref-type="supplementary-material" rid="sup2">Table S1</xref>). The cardinal features of BCD include the ectropion of the lower eyelids, euryblepharon and lagopthalmos (<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>); these were not evident. However, five of our patients showed other BCD-eyelid manifestations such as distichiasis and ankyloblepharon (<xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>); we also found short up-slanting palpebral fissures, hooded eyelids, high arched eyebrows and telecanthus (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material, Figure S1A</xref>; <xref ref-type="table" rid="TB2">Table 2</xref> and <xref ref-type="supplementary-material" rid="sup2">Supplementary Material, Table S1</xref>). As BCD is associated with both <italic>CTNND1</italic> and <italic>CDH1</italic> (E-cadherin) variants, some of these phenotypes may represent the distinctive functions of the E-cadherin-p120 complex; the majority of these functions could be attributed to a role for the cadherin-catenin in epithelia (<xref ref-type="bibr" rid="ref71">71</xref>).</p>
<p>Of note, eight individuals had severe hypodontia, including missing permanent canines and first permanent molars, even in those without cleft lip/palate. Thus, missing canines and molars could be classified as a microform cleft anomaly, especially when found in association with high-arched palate (<xref ref-type="bibr" rid="ref72">72</xref>) (<xref ref-type="fig" rid="f3">Fig. 3I and K</xref>; <xref ref-type="supplementary-material" rid="sup3">Supplementary Material, Table S2</xref>).</p>
<p>Beyond the known phenotypes associated with <italic>CTNND1</italic> and <italic>CDH1</italic>, we note the novel phenotypes seen in our patients, which include the heart anomalies and behavioral disorders. These have not been reported previously in patients with a BCD diagnosis. Nevertheless, our findings suggest that both <italic>CTNND1</italic> and <italic>CDH1</italic> should be tested in patients with congenital orofacial and cardiac anomalies. A key finding was choanal atresia in four individuals; given the rarity of this anomaly, both <italic>CTNND1</italic> and <italic>CDH1</italic> should be considered during genetic profiling of patients with this anomaly, in addition to CHARGE and other syndromes noted above. Indeed, Nishi <italic>et al</italic>. (<xref ref-type="bibr" rid="ref73">73</xref>) reported cleft lip, right choanal atresia, a congenital cardiac anomaly (tetralogy of Fallot), agenesis of the corpus callosum, up-slanted palpebral fissures and ear anomalies in a patient with <italic>CDH1</italic> mutation; however, at the time, this was not diagnosed as BCD.</p>
<p>While all of the variants found in the present study resulted in the truncations of p120-catenin, they fell broadly into three distinct groups: those falling within the N-terminal regulatory region (p.Val148Aspfs<sup>*</sup>24), those disrupting the armadillo repeat region and presumably subsequent interactions with E-cadherin (e.g. p.Arg461<sup>*</sup>, p.Arg797<sup>*</sup>, p.Leu494Argfs<sup>*</sup>5 and p.GLy532Alafs<sup>*</sup>6) and those falling in the C-terminal domain (p.Ser868<sup>*</sup>, the splice variant c.2702-5A&gt;G and p.His913Profs<sup>*</sup>3). Those falling in the N-terminal region would be predicted to have the most complete deletion and to best mimic a heterozygous loss of function situation. Indeed, similar to the heterozygous mice, these subjects did not have cleft palate. Interestingly, those probands with C-terminal truncations had the most complete cleft lip and palate phenotypes. This was consistent with previous reports by Kievit <italic>et al</italic>. (<xref ref-type="bibr" rid="ref1">1</xref>), who reported a non-sense mutation (p.Trp830<sup>*</sup>), and Cox <italic>et al</italic>. (<xref ref-type="bibr" rid="ref3">3</xref>), who reported p.Arg852<sup>*</sup> and a splice site mutation (c.2417+G&gt;T) (<xref ref-type="bibr" rid="ref3">3</xref>). As these C-terminal truncations would all be predicted to retain E-cadherin binding but lose crucial RhoGAP interactions (<xref ref-type="bibr" rid="ref24">24</xref>), one might hypothesize that a mutation in this region prevents p120 clearing from the epithelial complex, which is necessary for seam dissolution during palate closure. Therefore, future analyses should focus on whether these C-terminal truncations are acting in a dominant-negative manner, and preventing clearance of E-cadherin from the seam. It would also be useful to check whether any variants lead to non–sense-mediated decay, especially those lying in the armadillo domain, as Kievit and colleagues demonstrated (<xref ref-type="bibr" rid="ref2">2</xref>).</p>
<p>With regards to non-epithelial functions of p120, some of the phenotypes that this study, and others, has reported could be explained by the known interactions of p120 in the Wnt signalling pathway (<xref ref-type="bibr" rid="ref20">20</xref>). Epithelial-specific knockouts of p120 (using a <italic>keratin-14</italic> promoter) did not show tooth agenesis (<xref ref-type="bibr" rid="ref10">10</xref>), suggesting that the tooth anomalies in our patients do not arise from the epithelial functions of p120. In support of this, two key genes implicated in tooth agenesis are the Wnt ligand, <italic>Wnt10A</italic> and a Wnt target gene <italic>Axin2</italic> (<xref ref-type="bibr" rid="ref74">74–84</xref>). The Wnt signalling pathway may also explain the laryngeal findings (<xref ref-type="fig" rid="f6">Fig. 6</xref>), as the knockout of the Wnt transducer β-catenin is also known to lead to similar vocal fold anomalies (<xref ref-type="bibr" rid="ref85">85</xref>) as those seen in our neural crest-specific <italic>p120-catenin</italic> heterozygotes (<xref ref-type="fig" rid="f6">Fig. 6</xref>). Furthermore, by targeting isoform 1, we should be losing the mesenchymal form of p120 (<xref ref-type="fig" rid="f7">Figs 7</xref> and <xref ref-type="fig" rid="f8">8</xref>). These findings are consistent with prior studies focused on neural crest, where the p120-catenin association with Wnt signalling is well established (<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref87">87</xref>). Thus, we hypothesize that a subset of p120 phenotypes can also be attributed to Wnt perturbation in the neural crest (<xref ref-type="fig" rid="f9">Fig. 9</xref>).</p>
<fig id="f9" orientation="portrait" position="float">
<label>Figure 9</label>
<caption>
<p>Model of <italic>CTNND1</italic> function in systemic disease. (<bold>A</bold>) <italic>CTNND1</italic> mutations are not only implicated in conditions that affect epithelial structures but also systemic conditions that originate from mesenchymal roles of p120-catenin. Structures in pink circles have been described in previous publications on <italic>CTNND1</italic> (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>); structures in blue circles have been implicated previously in <italic>CTNND1</italic>-related disorders (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>) and in this study. Structures in yellow circles have been identified in this study. (<bold>B</bold>) BCD is primarily due to disturbances in E-cadherin/p120 interactions. The inclusion of other organ systems described here highlights the involvement of other known molecular functions of p120, such as its role in the WNT signalling pathway and its interactions with Rho-GTPases, demonstrating its mesenchymal roles in producing these systemic conditions.</p>
</caption>
<graphic xlink:href="ddaa050f9"></graphic>
</fig>
<p>The heart defects seen in our patients could also be attributed to a failure in neural crest development, which is known to be crucial for the development of the septum and valves (<xref ref-type="bibr" rid="ref88">88–92</xref>). Congenital heart disease (CHD) is the most common human birth defect with an incidence that varies between 0.8 and 2% in neonates (<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>). In addition, mild anomalies of the heart may be undiagnosed. In contrast, we noted that nearly half the subjects in our cohort have some form of CHD (6/13). Of the CHD incidences seen in live births, phenotypes can range from minor septal defects to severe malformations requiring lifesaving surgical repair. A similar range of anomalies was reflected across our cohort (<xref ref-type="table" rid="TB2">Table 2</xref>). Furthermore, within families with single gene mutations, different types of structural cardiac malformations may be observed (<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>). For example, we observed this in Family A, where both mother and daughter have septal defects but additional presentations vary (one has a hypoplastic aortic arch and mitral valve stenosis while the other has patent ductus arteriosus, <xref ref-type="table" rid="TB2">Table 2</xref>). Thus, a thorough survey of phenotypic variation and the inclusion of mild anomalies is important for generating new hypotheses on key roles for CTNND1 during human development. Future analysis will be necessary to definitely determine functional relevance of the different isoforms and the relationship with our novel patient variants.</p>
<p>In addition to the phenotypes shared commonly across our cohort, some participants in this study had scoliosis, and one family reported two deceased children, who had bifid uvula, congenital cardiac disease (VSD, PDS), eye anomalies, developmental delay and chronic bowel immotility and gastroesophageal reflux disease; however, no genetic testing had been carried out. One patient presented at a young age with an ovarian dysgerminoma. To our knowledge, this is the first patient with a <italic>CTNND1</italic> variant associated with an early onset cancer. Though p120 and E-cadherin have been associated with cancer and tumourigenesis (<xref ref-type="bibr" rid="ref23">23–25</xref>,<xref ref-type="bibr" rid="ref93">93–95</xref>), our data are insufficient to determine linkage in this case. Nevertheless, future studies of genetic cancers should consider E-cadherin/p120-catenin status as well.</p>
<p>Finally, a number of patients reported in DECIPHER have copy number variants (CNVs) affecting <italic>CTNND1</italic> (data not shown). Previously published missense mutations are noted in <xref ref-type="fig" rid="f1">Figure 1</xref>. Interestingly, for CNVs, both deletions and duplications have been associated with partially overlapping phenotypes. For instance, two patients with a deletion of less than 4 MB had anomalies including bulbous nose, limb anomalies, delayed speech and language development, intellectual disability, nasal speech, ventricular septal defect and cleft lip (data not shown). Further studies will be necessary to understand the functional consequences of these genetic changes.</p>
<p>In summary, we demonstrate that for the first time, p120 is not only involved in human conditions involving epithelial integrity, most likely caused by aberrant E-cadherin/p120 interactions, but also in other important intracellular functions (<xref ref-type="fig" rid="f9">Fig. 9</xref>). We conclude that <italic>CTNND1-</italic>related disorders span a spectrum of phenotypes ranging from multi-system involvement to non-syndromic clefting. While further studies will be necessary to definitively understand the phenotype-genotype correlations, <italic>CTNND1</italic>, and perhaps <italic>CDH1</italic>, should be considered when patients present with characteristic craniofacial anomalies, congenital cardiac defects and neurodevelopmental disorders.</p>
</sec>
<sec id="sec20">
<title>Declarations</title>
<p>S.A.L. is part owner of Qiyas Higher Health, a startup company unrelated to this work.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="sup1">
<label>Alharatani_p120_SupplFigLegends_ddaa050</label>
<media xlink:href="alharatani_p120_supplfiglegends_ddaa050.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="sup2">
<label>AlharataniSupplTable1_ddaa050</label>
<media xlink:href="alharatanisuppltable1_ddaa050.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="sup3">
<label>AlharataniSupplTable2_ddaa050</label>
<media xlink:href="alharatanisuppltable2_ddaa050.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="ddaa050-ack">
<title>Acknowledgements</title>
<p>We thank the patients and their families for their kind co-operation. We are grateful to the South Thames Cleft Team for their support, and to the Liu lab and colleagues in CCRB, especially Angela Gates, for support and feedback.</p>
</ack>
<sec id="sec20a">
<title>Funding</title>
<p>The HDBR, which provided human samples, is funded by Joint MRC/Wellcome Trust (grant # 099175/Z/12/Z). This study makes use of DECIPHER, which is funded by the Wellcome Trust. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of Wellcome or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. <italic>Xenopus</italic> experiments were additionally supported by the European Xenopus Resource Centre UK, the National Xenopus Resource USA and Xenbase. Work in the Liu lab is funded by Biotechnology and Biological Sciences Research Council (K.J.L.), British Heart Foundation (K.J.L./J.G.), the Medical Research Council (K.J.L.), the Faculty of Dental Surgery, Royal College of Surgeons of England—British Society of Paediatric Dentistry (FDS RCSEng-BSPD) Small Grant (R.A./M.T.H./K.J.L.), KSA (R.A.) and NIH/NIDDK DK099478 (D.K.M.).</p>
<p>
<italic>Conflict of Interest statement</italic>. None declared.</p>
</sec>
<ref-list id="bib1">
<title>References</title>
<ref id="ref1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kievit</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tessadori</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Douben</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jordens</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Maurice</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hoogeboom</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hennekam</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nampoothiri</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kayserili</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Castori</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Variants in members of the cadherin-catenin complex, CDH1 and CTNND1, cause blepharocheilodontic syndrome</article-title>. <source/>Eur. J. Hum. Genet., <volume>26</volume>, <fpage>210</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">29348693</pub-id></mixed-citation>
</ref>
<ref id="ref2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ghoumid</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Stichelbout</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jourdain</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Frenois</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lejeune-Dumoulin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Alex-Cordier</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Lebrun</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guerreschi</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Duquennoy-Martinot</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Vinchon</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1</article-title>. <source/>Genet. Med., <volume>19</volume>, <fpage>1013</fpage>–<lpage>1021</lpage>.<pub-id pub-id-type="pmid">28301459</pub-id></mixed-citation>
</ref>
<ref id="ref3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>L.L.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>T.C.</given-names></name>, <name name-style="western"><surname>Moreno Uribe</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>C.T.</given-names></name>, <name name-style="western"><surname>Nidey</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Standley</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Blue</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>J.X.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>Mutations in the epithelial cadherin-p120-catenin complex cause Mendelian non-Syndromic cleft lip with or without cleft palate</article-title>. <source/>Am. J. Hum. Genet., <volume>102</volume>, <fpage>1143</fpage>–<lpage>1157</lpage>.<pub-id pub-id-type="pmid">29805042</pub-id></mixed-citation>
</ref>
<ref id="ref4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perez-Moreno</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pasolli</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name> and <name name-style="western"><surname>Fuchs</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>) <article-title>p120-catenin mediates inflammatory responses in the skin</article-title>. <source/>Cell, <volume>124</volume>, <fpage>631</fpage>–<lpage>644</lpage>.<pub-id pub-id-type="pmid">16469707</pub-id></mixed-citation>
</ref>
<ref id="ref5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Oas</surname><given-names>R.G.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Summers</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wittich</surname><given-names>K.B.</given-names></name>, <name name-style="western"><surname>Chiasson</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>W.D.</given-names></name>, <name name-style="western"><surname>Grossniklaus</surname><given-names>H.E.</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name> and <name name-style="western"><surname>Kowalczyk</surname><given-names>A.P.</given-names></name></person-group> (<year>2010</year>) <article-title>p120-catenin is required for mouse vascular development</article-title>. <source/>Circ. Res., <volume>106</volume>, <fpage>941</fpage>.<pub-id pub-id-type="pmid">20110533</pub-id></mixed-citation>
</ref>
<ref id="ref6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Marciano</surname><given-names>D.K.</given-names></name>, <name name-style="western"><surname>Brakeman</surname><given-names>P.R.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C.-Z.</given-names></name>, <name name-style="western"><surname>Spivak</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Eastburn</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Bryant</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Beaudoin</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Hofmann</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Mostov</surname><given-names>K.E.</given-names></name> and <name name-style="western"><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group> (<year>2011</year>) <article-title>p120 catenin is required for normal renal tubulogenesis and glomerulogenesis</article-title>. <source/>Development, <volume>138</volume>, <fpage>2099</fpage>–<lpage>2109</lpage>.<pub-id pub-id-type="pmid">21521738</pub-id></mixed-citation>
</ref>
<ref id="ref7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hendley</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Provost</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.J.</given-names></name>, <name name-style="western"><surname>Cleveland</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bittman</surname><given-names>R.W.</given-names></name>, <name name-style="western"><surname>Roeser</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Maitra</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2015</year>) <article-title>p120 catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas</article-title>. <source/>Dev. Biol., <volume>399</volume>, <fpage>41</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">25523391</pub-id></mixed-citation>
</ref>
<ref id="ref8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Elia</surname><given-names>L.P.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zang</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group> (<year>2006</year>) <article-title>p120 catenin regulates dendritic spine and synapse development through rho-family GTPases and cadherins</article-title>. <source/>Neuron, <volume>51</volume>, <fpage>43</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">16815331</pub-id></mixed-citation>
</ref>
<ref id="ref9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2006</year>) <article-title>Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland</article-title>. <source/>Dev. Cell, <volume>10</volume>, <fpage>21</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">16399075</pub-id></mixed-citation>
</ref>
<ref id="ref10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bartlett</surname><given-names>J.D.</given-names></name>, <name name-style="western"><surname>Dobeck</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Tye</surname><given-names>C.E.</given-names></name>, <name name-style="western"><surname>Perez-Moreno</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stokes</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Skobe</surname><given-names>Z.</given-names></name></person-group> (<year>2010</year>) <article-title>Targeted p120-catenin ablation disrupts dental enamel development</article-title>. <source/>PLoS One, <volume>5</volume>, <fpage>e12703</fpage>.<pub-id pub-id-type="pmid">20862276</pub-id></mixed-citation>
</ref>
<ref id="ref11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ciesiolka</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Delvaeye</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Van Imschoot</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Verschuere</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>McCrea</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Van Roy</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Vleminckx</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>) <article-title>p120 catenin is required for morphogenetic movements involved in the formation of the eyes and the craniofacial skeleton in Xenopus</article-title>. <source/>J. Cell Sci., <volume>117</volume>, <fpage>4325</fpage>–<lpage>4339</lpage>.<pub-id pub-id-type="pmid">15292404</pub-id></mixed-citation>
</ref>
<ref id="ref12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Geis</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Aberle</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kühl</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kemler</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Wedlich</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>) <article-title>Expression of the Armadillo family member p120 cas 1B in Xenopus embryos affects head differentiation but not axis formation</article-title>. <source/>Dev. Genes Evol., <volume>207</volume>, <fpage>471</fpage>–<lpage>481</lpage>.<pub-id pub-id-type="pmid">9510542</pub-id></mixed-citation>
</ref>
<ref id="ref13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ishiyama</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.-H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G.-Y.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Reichardt</surname><given-names>L.F.</given-names></name> and <name name-style="western"><surname>Ikura</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>) <article-title>Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion</article-title>. <source/>Cell, <volume>141</volume>, <fpage>117</fpage>–<lpage>128</lpage>.<pub-id pub-id-type="pmid">20371349</pub-id></mixed-citation>
</ref>
<ref id="ref14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ireton</surname><given-names>R.C.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>van Hengel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mariner</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Thoreson</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Anastasiadis</surname><given-names>P.Z.</given-names></name>, <name name-style="western"><surname>Matrisian</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bundy</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Sealy</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>) <article-title>A novel role for p120 catenin in E-cadherin function</article-title>. <source/>J. Cell Biol., <volume>159</volume>, <fpage>465</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">12427869</pub-id></mixed-citation>
</ref>
<ref id="ref15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fukumoto</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shintani</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>K.R.</given-names></name> and <name name-style="western"><surname>Wheelock</surname><given-names>M.J.</given-names></name></person-group> (<year>2008</year>) <article-title>The regulatory or phosphorylation domain of p120 catenin controls E-cadherin dynamics at the plasma membrane</article-title>. <source/>Exp. Cell Res., <volume>314</volume>, <fpage>52</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">17719574</pub-id></mixed-citation>
</ref>
<ref id="ref16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Ireton</surname><given-names>R.C.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2003</year>) <article-title>A core function for p120-catenin in cadherin turnover</article-title>. <source/>J. Cell Biol., <volume>163</volume>, <fpage>525</fpage>–<lpage>534</lpage>.<pub-id pub-id-type="pmid">14610055</pub-id></mixed-citation>
</ref>
<ref id="ref17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Daniel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Wheelock</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>1994</year>) <article-title>Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes</article-title>. <source/>Mol. Cell. Biol., <volume>14</volume>, <fpage>8333</fpage>–<lpage>8342</lpage>.<pub-id pub-id-type="pmid">7526156</pub-id></mixed-citation>
</ref>
<ref id="ref18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anastasiadis</surname><given-names>P.Z.</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Thoreson</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Mariner</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Crawford</surname><given-names>H.C.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2000</year>) <article-title>Inhibition of RhoA by p120 catenin</article-title>. <source/>Nat. Cell Biol., <volume>2</volume>, <fpage>637</fpage>.<pub-id pub-id-type="pmid">10980705</pub-id></mixed-citation>
</ref>
<ref id="ref19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wildenberg</surname><given-names>G.A.</given-names></name>, <name name-style="western"><surname>Dohn</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Carnahan</surname><given-names>R.H.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Lobdell</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Settleman</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2006</year>) <article-title>p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and rho</article-title>. <source/>Cell, <volume>127</volume>, <fpage>1027</fpage>–<lpage>1039</lpage>.<pub-id pub-id-type="pmid">17129786</pub-id></mixed-citation>
</ref>
<ref id="ref20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.I.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>T.T.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Barton</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Deroo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vleminckx</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2005</year>) <article-title>Kaiso/p120-catenin and TCF/β-catenin complexes coordinately regulate canonical Wnt gene targets</article-title>. <source/>Dev. Cell, <volume>8</volume>, <fpage>843</fpage>–<lpage>854</lpage>.<pub-id pub-id-type="pmid">15935774</pub-id></mixed-citation>
</ref>
<ref id="ref21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>del Valle-Pérez</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Casagolda</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lugilde</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Valls</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Codina</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dave</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>de Herreros</surname><given-names>A.G.</given-names></name> and <name name-style="western"><surname>Duñach</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>) <article-title>Wnt controls the transcriptional activity of Kaiso through CK1ε-dependent phosphorylation of p120-catenin</article-title>. <source/>J. Cell Sci., <volume>124</volume>, <fpage>2298</fpage>–<lpage>2309</lpage>.<pub-id pub-id-type="pmid">21670201</pub-id></mixed-citation>
</ref>
<ref id="ref22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yanagisawa</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Anastasiadis</surname><given-names>P.Z.</given-names></name></person-group> (<year>2006</year>) <article-title>p120 catenin is essential for mesenchymal cadherin–mediated regulation of cell motility and invasiveness</article-title>. <source/>J. Cell Biol., <volume>174</volume>, <fpage>1087</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">16982802</pub-id></mixed-citation>
</ref>
<ref id="ref23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stairs</surname><given-names>D.B.</given-names></name>, <name name-style="western"><surname>Bayne</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Rhoades</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Vega</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Waldron</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Kalabis</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Klein-Szanto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Diehl</surname><given-names>J.A.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>) <article-title>Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene</article-title>. <source/>Cancer Cell, <volume>19</volume>, <fpage>470</fpage>–<lpage>483</lpage>.<pub-id pub-id-type="pmid">21481789</pub-id></mixed-citation>
</ref>
<ref id="ref24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schackmann</surname><given-names>R.C.</given-names></name>, <name name-style="western"><surname>Tenhagen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van de Ven</surname><given-names>R.A.</given-names></name> and <name name-style="western"><surname>Derksen</surname><given-names>P.W.</given-names></name></person-group> (<year>2013</year>) <article-title>p120-catenin in cancer–mechanisms, models and opportunities for intervention</article-title>. <source/>J. Cell Sci., <volume>126</volume>, <fpage>3515</fpage>–<lpage>3525</lpage>.<pub-id pub-id-type="pmid">23950111</pub-id></mixed-citation>
</ref>
<ref id="ref25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name> and <name name-style="western"><surname>Roczniak-Ferguson</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>) <article-title>Emerging roles for p120-catenin in cell adhesion and cancer</article-title>. <source/>Oncogene, <volume>23</volume>, <fpage>7947</fpage>.<pub-id pub-id-type="pmid">15489912</pub-id></mixed-citation>
</ref>
<ref id="ref26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>N.A.</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Copeland</surname><given-names>N.G.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Daniel</surname><given-names>J.M.</given-names></name></person-group> (<year>1996</year>) <article-title>The gene encoding p120cas, a novel catenin, localizes on human chromosome 11q11 (CTNND) and mouse chromosome 2 (Catns)</article-title>. <source/>Genomics, <volume>31</volume>, <fpage>127</fpage>–<lpage>129</lpage>.<pub-id pub-id-type="pmid">8808291</pub-id></mixed-citation>
</ref>
<ref id="ref27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Montonen</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Aho</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Uitto</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Aho</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>) <article-title>Tissue distribution and cell type-specific expression of p120ctn isoforms</article-title>. <source/>J. Histochem. Cytochem., <volume>49</volume>, <fpage>1487</fpage>–<lpage>1495</lpage>.<pub-id pub-id-type="pmid">11724896</pub-id></mixed-citation>
</ref>
<ref id="ref28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Aho</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Levänsuo</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Montonen</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Kari</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rodeck</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Uitto</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>) <article-title>Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells</article-title>. <source/>J. Cell Sci., <volume>115</volume>, <fpage>1391</fpage>–<lpage>1402</lpage>.<pub-id pub-id-type="pmid">11896187</pub-id></mixed-citation>
</ref>
<ref id="ref29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>I.-H.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2016</year>) <article-title>Phosphorylation and isoform use in p120-catenin during development and tumorigenesis</article-title>. <source/>Biochim. Biophys. Acta Mol. Cell Res., <source/>114, <volume>1863</volume>, <fpage>102</fpage>.</mixed-citation>
</ref>
<ref id="ref30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Keirsebilck</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bonné</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Staes</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>van Hengel</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nollet</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Van Roy</surname><given-names>F.</given-names></name></person-group> (<year>1998</year>) <article-title>Molecular cloning of the human p120ctnCatenin gene (CTNND1): expression of multiple alternatively spliced isoforms</article-title>. <source/>Genomics, <volume>50</volume>, <fpage>129</fpage>–<lpage>146</lpage>.<pub-id pub-id-type="pmid">9653641</pub-id></mixed-citation>
</ref>
<ref id="ref31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mariner</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2000</year>) <article-title>ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120 (ctn) in E-cadherin complexes</article-title>. <source/>J. Cell Sci., <volume>113</volume>, <fpage>1481</fpage>–<lpage>1490</lpage>.<pub-id pub-id-type="pmid">10725230</pub-id></mixed-citation>
</ref>
<ref id="ref32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hatzfeld</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>) <article-title>The p120 family of cell adhesion molecules</article-title>. <source/>Eur. J. Cell Biol., <volume>84</volume>, <fpage>205</fpage>–<lpage>214</lpage>.<pub-id pub-id-type="pmid">15819401</pub-id></mixed-citation>
</ref>
<ref id="ref33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sater</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stratton</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Barton</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2009</year>) <article-title>Xenopus δ-catenin is essential in early embryogenesis and is functionally linked to cadherins and small GTPases</article-title>. <source/>J. Cell Sci., <volume>122</volume>, <fpage>4049</fpage>–<lpage>4061</lpage>.<pub-id pub-id-type="pmid">19843587</pub-id></mixed-citation>
</ref>
<ref id="ref34">
<label>34.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>T.N.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>E.C.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.P.</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Sosa</surname><given-names>M.X.</given-names></name>, <name name-style="western"><surname>Auer</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Brand</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Loss of delta-catenin function in severe autism</article-title>. <source/>Nature, <volume>520</volume>, <fpage>51</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">25807484</pub-id></mixed-citation>
</ref>
<ref id="ref35">
<label>35.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Aguilar</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Chen</surname><given-names>Y.-H.</given-names></name></person-group> (<year>2016</year>) <article-title>Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases</article-title>. <source/>Hum. Genet., <volume>135</volume>, <fpage>1107</fpage>–<lpage>1116</lpage>.<pub-id pub-id-type="pmid">27380241</pub-id></mixed-citation>
</ref>
<ref id="ref36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Medina</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Marinescu</surname><given-names>R.C.</given-names></name>, <name name-style="western"><surname>Overhauser</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Kosik</surname><given-names>K.S.</given-names></name></person-group> (<year>2000</year>) <article-title>Hemizygosity of δ-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome</article-title>. <source/>Genomics, <volume>63</volume>, <fpage>157</fpage>–<lpage>164</lpage>.<pub-id pub-id-type="pmid">10673328</pub-id></mixed-citation>
</ref>
<ref id="ref37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hofmeister</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Nilsson</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Topa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Anderlid</surname><given-names>B.M.</given-names></name>, <name name-style="western"><surname>Darki</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Matsson</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tapia Paez</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Klingberg</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Samuelsson</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wirta</surname><given-names>V.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>CTNND2-a candidate gene for reading problems and mild intellectual disability</article-title>. <source/>J. Med. Genet., <volume>52</volume>, <fpage>111</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="pmid">25473103</pub-id></mixed-citation>
</ref>
<ref id="ref38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nivard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mbarek</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hottenga</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Smit</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Jansen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Penninx</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Middeldorp</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Boomsma</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>) <article-title>Further confirmation of the association between anxiety and CTNND2: replication in humans</article-title>. <source/>Genes Brain Behav., <volume>13</volume>, <fpage>195</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">24256404</pub-id></mixed-citation>
</ref>
<ref id="ref39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Belcaro</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dipresa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Morini</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Pecile</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Skabar</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Fabretto</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>) <article-title>CTNND2 deletion and intellectual disability</article-title>. <source/>Gene, <volume>565</volume>, <fpage>146</fpage>–<lpage>149</lpage>.<pub-id pub-id-type="pmid">25839933</pub-id></mixed-citation>
</ref>
<ref id="ref40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sirotkin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>O'Donnell</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>DasGupta</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Halford</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>St Jore</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Puech</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Parimoo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Morrow</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Skoultchi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Weissman</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Scambler</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Kucherlapati</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>) <article-title>Identification of a new human catenin gene family member (ARVCF) from the region deleted in velo-cardio-facial syndrome</article-title>. <source/>Genomics, <volume>41</volume>, <fpage>75</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">9126485</pub-id></mixed-citation>
</ref>
<ref id="ref41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Butts</surname><given-names>S.C.</given-names></name></person-group> (<year>2009</year>) <article-title>The facial phenotype of the velo-cardio-facial syndrome</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol., <volume>73</volume>, <fpage>343</fpage>–<lpage>350</lpage>.<pub-id pub-id-type="pmid">19062108</pub-id></mixed-citation>
</ref>
<ref id="ref42">
<label>42.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shprintzen</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Goldberg</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lewin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sidoti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Berkman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Argamaso</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Young</surname><given-names>D.</given-names></name></person-group> (<year>1978</year>) <article-title>A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome</article-title>. <source/>Cleft Palate J., <volume>15</volume>, <fpage>56</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">272242</pub-id></mixed-citation>
</ref>
<ref id="ref43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>W.A.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kloc</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2011</year>) <article-title>Kazrin, and its binding partners ARVCF-and delta-catenin, are required for Xenopus laevis craniofacial development</article-title>. <source/>Dev. Dyn., <volume>240</volume>, <fpage>2601</fpage>–<lpage>2612</lpage>.<pub-id pub-id-type="pmid">22028074</pub-id></mixed-citation>
</ref>
<ref id="ref44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab>, <name name-style="western"><surname>McRae</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Clayton</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>T.W.</given-names></name>, <name name-style="western"><surname>Kaplanis</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Prigmore</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rajan</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sifrim</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aitken</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Akawi</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>. <source/>Nature, <volume>542</volume>, <fpage>433</fpage>.<pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
</ref>
<ref id="ref45">
<label>45.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Kaufman</surname><given-names>M.H.</given-names></name> and <name name-style="western"><surname>Kaufman</surname><given-names>M.H.</given-names></name></person-group> (<year>1992</year>) <source/>The Atlas of Mouse Development.
<publisher-name>Academic Press</publisher-name>, <publisher-loc>London</publisher-loc>.</mixed-citation>
</ref>
<ref id="ref46">
<label>46.</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Lewandoski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meyers</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Martin</surname><given-names>G.</given-names></name></person-group> (<year>1997</year>) <chapter-title>Analysis of Fgf8 gene function in vertebrate development</chapter-title> In <source/>Cold Spring Harb Symp Quant Biol.
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, pp. <fpage>159</fpage>–<lpage>168</lpage>.</mixed-citation>
</ref>
<ref id="ref47">
<label>47.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Vasudevan</surname><given-names>H.N.</given-names></name>, <name name-style="western"><surname>O’Neill</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Soriano</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Bush</surname><given-names>J.O.</given-names></name></person-group> (<year>2013</year>) <article-title>The widely used Wnt1-Cre transgene causes developmental phenotypes by ectopic activation of Wnt signaling</article-title>. <source/>Dev. Biol., <volume>379</volume>, <fpage>229</fpage>–<lpage>234</lpage>.<pub-id pub-id-type="pmid">23648512</pub-id></mixed-citation>
</ref>
<ref id="ref48">
<label>48.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Khokha</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bustamante</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Gaw</surname><given-names>L.W.</given-names></name>, <name name-style="western"><surname>Trott</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Taverner</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Amaya</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>) <article-title>Techniques and probes for the study of <italic>Xenopus tropicalis</italic> development</article-title>. <source/>Dev. Dyn., <volume>225</volume>, <fpage>499</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">12454926</pub-id></mixed-citation>
</ref>
<ref id="ref49">
<label>49.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rual</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Hirozane-Kishikawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bertin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Dricot</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lamesch</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vidalain</surname><given-names>P.O.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>) <article-title>Human ORFeome version 1.1: a platform for reverse proteomics</article-title>. <source/>Genome Res., <volume>14</volume>, <fpage>2128</fpage>–<lpage>2135</lpage>.<pub-id pub-id-type="pmid">15489335</pub-id></mixed-citation>
</ref>
<ref id="ref50">
<label>50.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Bailes</surname><given-names>J.A.</given-names></name> and <name name-style="western"><surname>McMahon</surname><given-names>A.P.</given-names></name></person-group> (<year>1987</year>) <article-title>Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo</article-title>. <source/>Cell, <volume>50</volume>, <fpage>79</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">3594565</pub-id></mixed-citation>
</ref>
<ref id="ref51">
<label>51.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Karczewski</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Francioli</surname><given-names>L.C.</given-names></name>, <name name-style="western"><surname>Tiao</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>B.B.</given-names></name>, <name name-style="western"><surname>Alföldi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Collins</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Laricchia</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Ganna</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Birnbaum</surname><given-names>D.P.</given-names></name><etal>et al.</etal></person-group> (<year>2019</year>) <article-title>Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes</article-title>. <source/>bioRxiv. doi.org/10/1101/531210.</mixed-citation>
</ref>
<ref id="ref52">
<label>52.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Mariner</surname><given-names>D.J.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2003</year>) <article-title>Adhesion-associated and PKC-modulated changes in serine/threonine phosphorylation of p120-catenin</article-title>. <source/>Biochemistry (Mosc), <volume>42</volume>, <fpage>9195</fpage>–<lpage>9204</lpage>.</mixed-citation>
</ref>
<ref id="ref53">
<label>53.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vinyoles</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Del Valle-Pérez</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Curto</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Viñas-Castells</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Alba-Castellón</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>de Herreros</surname><given-names>A.G.</given-names></name> and <name name-style="western"><surname>Duñach</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>) <article-title>Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin/cadherin interaction with LRP5/6</article-title>. <source/>Mol. Cell, <volume>53</volume>, <fpage>444</fpage>–<lpage>457</lpage>.<pub-id pub-id-type="pmid">24412065</pub-id></mixed-citation>
</ref>
<ref id="ref54">
<label>54.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Mcalmon</surname><given-names>K.R.</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Bernfield</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Hay</surname><given-names>E.D.</given-names></name></person-group> (<year>2003</year>) <article-title>Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation</article-title>. <source/>Int. J. Dev. Biol., <volume>42</volume>, <fpage>733</fpage>–<lpage>736</lpage>.</mixed-citation>
</ref>
<ref id="ref55">
<label>55.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mariner</surname><given-names>D.J.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2004</year>) <article-title>EGFR signaling to p120-catenin through phosphorylation at Y228</article-title>. <source/>J. Cell Sci., <volume>117</volume>, <fpage>1339</fpage>–<lpage>1350</lpage>.<pub-id pub-id-type="pmid">14996911</pub-id></mixed-citation>
</ref>
<ref id="ref56">
<label>56.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leopold</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>De Barros</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Cellier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Drouin-Garraud</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Dehesdin</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Marie</surname><given-names>J.-P.</given-names></name></person-group> (<year>2012</year>) <article-title>Laryngeal abnormalities are frequent in the 22q11 deletion syndrome</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol., <volume>76</volume>, <fpage>36</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">22019154</pub-id></mixed-citation>
</ref>
<ref id="ref57">
<label>57.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Miyamoto</surname><given-names>R.C.</given-names></name>, <name name-style="western"><surname>Cotton</surname><given-names>R.T.</given-names></name>, <name name-style="western"><surname>Rope</surname><given-names>A.F.</given-names></name>, <name name-style="western"><surname>Hopkin</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Shott</surname><given-names>S.R.</given-names></name> and <name name-style="western"><surname>Rutter</surname><given-names>M.J.</given-names></name></person-group> (<year>2004</year>) <article-title>Association of anterior glottic webs with velocardiofacial syndrome (chromosome 22q11. 2 deletion)</article-title>. <source/>Otolaryngol. Head Neck Surg., <volume>130</volume>, <fpage>415</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">15100636</pub-id></mixed-citation>
</ref>
<ref id="ref58">
<label>58.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fokstuen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bottani</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Medeiros</surname><given-names>P.F.</given-names></name>, <name name-style="western"><surname>Antonarakis</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Stoll</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Schinzel</surname><given-names>A.</given-names></name></person-group> (<year>1997</year>) <article-title>Laryngeal atresia type III (glottic web) with 22q11. 2 microdeletion: report of three patients</article-title>. <source/>Am. J. Med. Genet., <volume>70</volume>, <fpage>130</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">9128930</pub-id></mixed-citation>
</ref>
<ref id="ref59">
<label>59.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shawlot</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Fohn</surname><given-names>L.E.</given-names></name> and <name name-style="western"><surname>Behringer</surname><given-names>R.R.</given-names></name></person-group> (<year>1998</year>) <article-title>Restricted β-galactosidase expression of a hygromycin-lacZ gene targeted to the β-actin locus and embryonic lethality of β-actin mutant mice</article-title>. <source/>Transgenic Res., <volume>7</volume>, <fpage>95</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">9608737</pub-id></mixed-citation>
</ref>
<ref id="ref60">
<label>60.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Elder</surname><given-names>P.K.</given-names></name>, <name name-style="western"><surname>French</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Subramaniam</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>L.J.</given-names></name> and <name name-style="western"><surname>Getz</surname><given-names>M.J.</given-names></name></person-group> (<year>1988</year>) <article-title>Evidence that the functional beta-actin gene is single copy in most mice and is associated with 5′sequences capable of conferring serum-and cycloheximide-dependent regulation</article-title>. <source/>Mol. Cell. Biol., <volume>8</volume>, <fpage>480</fpage>–<lpage>485</lpage>.<pub-id pub-id-type="pmid">3422100</pub-id></mixed-citation>
</ref>
<ref id="ref61">
<label>61.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tabler</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Rigney</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Berman</surname><given-names>G.J.</given-names></name>, <name name-style="western"><surname>Gopalakrishnan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Heude</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Al-Lami</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Yannakoudakis</surname><given-names>B.Z.</given-names></name>, <name name-style="western"><surname>Fitch</surname><given-names>R.D.</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Vokes</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Cilia-mediated Hedgehog signaling controls form and function in the mammalian larynx</article-title>. <source/>Elife, <volume>6</volume>, pii:<fpage>e19153</fpage>.<pub-id pub-id-type="pmid">28177282</pub-id></mixed-citation>
</ref>
<ref id="ref62">
<label>62.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Danielian</surname><given-names>P.S.</given-names></name>, <name name-style="western"><surname>Muccino</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Rowitch</surname><given-names>D.H.</given-names></name>, <name name-style="western"><surname>Michael</surname><given-names>S.K.</given-names></name> and <name name-style="western"><surname>McMahon</surname><given-names>A.P.</given-names></name></person-group> (<year>1998</year>) <article-title>Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase</article-title>. <source/>Curr. Biol., <volume>8</volume>, <fpage>1323</fpage>–<lpage>S1322</lpage>.<pub-id pub-id-type="pmid">9843687</pub-id></mixed-citation>
</ref>
<ref id="ref63">
<label>63.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Paulson</surname><given-names>A.F.</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>1999</year>) <article-title>Misexpression of the catenin p120ctn1A PerturbsXenopusGastrulation but does not elicit Wnt-directed Axis specification</article-title>. <source/>Dev. Biol., <volume>207</volume>, <fpage>350</fpage>–<lpage>363</lpage>.<pub-id pub-id-type="pmid">10068468</pub-id></mixed-citation>
</ref>
<ref id="ref64">
<label>64.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bhattacharya</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Marfo</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Khokha</surname><given-names>M.K.</given-names></name></person-group> (<year>2015</year>) <article-title>CRISPR/Cas9: an inexpensive, efficient loss of function tool to screen human disease genes in Xenopus</article-title>. <source/>Dev. Biol., <volume>408</volume>, <fpage>196</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">26546975</pub-id></mixed-citation>
</ref>
<ref id="ref65">
<label>65.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Corsten-Janssen</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Saitta</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Hoefsloot</surname><given-names>L.H.</given-names></name>, <name name-style="western"><surname>McDonald-McGinn</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Driscoll</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Derks</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dickinson</surname><given-names>K.A.</given-names></name>, <name name-style="western"><surname>Kerstjens-Frederikse</surname><given-names>W.S.</given-names></name>, <name name-style="western"><surname>Emanuel</surname><given-names>B.S.</given-names></name>, <name name-style="western"><surname>Zackai</surname><given-names>E.H.</given-names></name> and <name name-style="western"><surname>van Ravenswaaij-Arts</surname><given-names>C.M.</given-names></name></person-group> (<year>2013</year>) <article-title>More clinical overlap between 22q11.2 deletion syndrome and CHARGE syndrome than often anticipated</article-title>. <source/>Mol. Syndromol., <volume>4</volume>, <fpage>235</fpage>–<lpage>245</lpage>.<pub-id pub-id-type="pmid">23885230</pub-id></mixed-citation>
</ref>
<ref id="ref66">
<label>66.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vissers</surname><given-names>L.E.</given-names></name>, <name name-style="western"><surname>van Ravenswaaij</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Admiraal</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>de Vries</surname><given-names>B.B.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>I.M.</given-names></name>, <name name-style="western"><surname>van der Vliet</surname><given-names>W.A.</given-names></name>, <name name-style="western"><surname>Huys</surname><given-names>E.H.</given-names></name>, <name name-style="western"><surname>de Jong</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Hamel</surname><given-names>B.C.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>) <article-title>Mutations in a new member of the chromodomain gene family cause CHARGE syndrome</article-title>. <source/>Nat. Genet., <volume>36</volume>, <fpage>955</fpage>–<lpage>957</lpage>.<pub-id pub-id-type="pmid">15300250</pub-id></mixed-citation>
</ref>
<ref id="ref67">
<label>67.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>M.T.</given-names></name>, <name name-style="western"><surname>Schölvinck</surname><given-names>E.H.</given-names></name>, <name name-style="western"><surname>Lambeck</surname><given-names>A.J.</given-names></name> and <name name-style="western"><surname>van Ravenswaaij-Arts</surname><given-names>C.M.</given-names></name></person-group> (<year>2015</year>) <article-title>CHARGE syndrome: a review of the immunological aspects</article-title>. <source/>Eur. J. Hum. Genet., <volume>23</volume>, <fpage>1451</fpage>.<pub-id pub-id-type="pmid">25689927</pub-id></mixed-citation>
</ref>
<ref id="ref68">
<label>68.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Goos</surname><given-names>J.A.C.</given-names></name>, <name name-style="western"><surname>Swagemakers</surname><given-names>S.M.A.</given-names></name>, <name name-style="western"><surname>Twigg</surname><given-names>S.R.F.</given-names></name>, <name name-style="western"><surname>van Dooren</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Hoogeboom</surname><given-names>A.J.M.</given-names></name>, <name name-style="western"><surname>Beetz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gunther</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Magielsen</surname><given-names>F.J.</given-names></name>, <name name-style="western"><surname>Ockeloen</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>M</surname><given-names>A.R.A.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>) <article-title>Identification of causative variants in TXNL4A in Burn-McKeown syndrome and isolated choanal atresia</article-title>. <source/>Eur. J. Hum. Genet., <volume>25</volume>, <fpage>1126</fpage>–<lpage>1133</lpage>.<pub-id pub-id-type="pmid">28905882</pub-id></mixed-citation>
</ref>
<ref id="ref69">
<label>69.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>V.L.G.d.S.</given-names></name>, <name name-style="western"><surname>Guion-Almeida</surname><given-names>M.L.</given-names></name>, and <name name-style="western"><surname>Rodini</surname><given-names>E.S.d.O.</given-names></name></person-group> (<year>2003</year>) <article-title>Blepharocheilodontic (BCD) syndrome: expanding the phenotype?</article-title><source/>Am. J. Med. Genet. A, <volume>121</volume>, <fpage>266</fpage>–<lpage>270</lpage>.</mixed-citation>
</ref>
<ref id="ref70">
<label>70.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ababneh</surname><given-names>F.K.</given-names></name>, <name name-style="western"><surname>Al-Swaid</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Elhag</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Youssef</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Alsaif</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>) <article-title>Blepharo-cheilo-dontic (BCD) syndrome: expanding the phenotype, case report and review of literature</article-title>. <source/>Am. J. Med. Genet. A, <volume>164</volume>, <fpage>1525</fpage>–<lpage>1529</lpage>.</mixed-citation>
</ref>
<ref id="ref71">
<label>71.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hammond</surname><given-names>N.L.</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Dixon</surname><given-names>M.J.</given-names></name></person-group> (<year>2017</year>) <article-title>Periderm: life-cycle and function during orofacial and epidermal development</article-title>. <source/>Semin. Cell Dev. Biol., <volume>91</volume>:<fpage>75</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">28803895</pub-id></mixed-citation>
</ref>
<ref id="ref72">
<label>72.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Abe</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Shimooka</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>) <article-title>Maxillary first molar agenesis and other dental anomalies</article-title>. <source/>Angle Orthod., <volume>80</volume>, <fpage>1002</fpage>–<lpage>1009</lpage>.<pub-id pub-id-type="pmid">20677947</pub-id></mixed-citation>
</ref>
<ref id="ref73">
<label>73.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nishi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Masuda</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Arakawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kawame</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kosho</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kitahara</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Hidaka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Katoh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shirahige</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Izumi</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>) <article-title>Exome sequencing-based identification of mutations in non-syndromic genes among individuals with apparently syndromic features</article-title>. <source/>Am. J. Med. Genet. A, <volume>170</volume>, <fpage>2889</fpage>–<lpage>2894</lpage>.<pub-id pub-id-type="pmid">27566442</pub-id></mixed-citation>
</ref>
<ref id="ref74">
<label>74.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lohi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tucker</surname><given-names>A.S.</given-names></name> and <name name-style="western"><surname>Sharpe</surname><given-names>P.T.</given-names></name></person-group> (<year>2010</year>) <article-title>Expression of Axin2 indicates a role for canonical Wnt signaling in development of the crown and root during pre-and postnatal tooth development</article-title>. <source/>Dev. Dyn., <volume>239</volume>, <fpage>160</fpage>–<lpage>167</lpage>.<pub-id pub-id-type="pmid">19653310</pub-id></mixed-citation>
</ref>
<ref id="ref75">
<label>75.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Laurikkala</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mikkola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mustonen</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Åberg</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Koppinen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Pispa</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nieminen</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Galceran</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Grosschedl</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Thesleff</surname><given-names>I.</given-names></name></person-group> (<year>2001</year>) <article-title>TNF signaling via the ligand–receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis</article-title>. <source/>Dev. Biol., <volume>229</volume>, <fpage>443</fpage>–<lpage>455</lpage>.<pub-id pub-id-type="pmid">11203701</pub-id></mixed-citation>
</ref>
<ref id="ref76">
<label>76.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name> and <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>) <article-title>Expression patterns of WNT/β-CATENIN signaling molecules during human tooth development</article-title>. <source/>J. Mol. Histol., <volume>45</volume>, <fpage>487</fpage>–<lpage>496</lpage>.<pub-id pub-id-type="pmid">24647585</pub-id></mixed-citation>
</ref>
<ref id="ref77">
<label>77.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>E.Y.</given-names></name>, <name name-style="western"><surname>Watt</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gallant</surname><given-names>N.M.</given-names></name>, <name name-style="western"><surname>Andl</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S.H.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Piccolo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schmidt-Ullrich</surname><given-names>R.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>) <article-title>Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis</article-title>. <source/>Dev. Biol., <volume>313</volume>, <fpage>210</fpage>–<lpage>224</lpage>.<pub-id pub-id-type="pmid">18022614</pub-id></mixed-citation>
</ref>
<ref id="ref78">
<label>78.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lammi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Arte</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Somer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Järvinen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lahermo</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Thesleff</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Pirinen</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Nieminen</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>) <article-title>Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer</article-title>. <source/>Am. J. Hum. Genet., <volume>74</volume>, <fpage>1043</fpage>–<lpage>1050</lpage>.<pub-id pub-id-type="pmid">15042511</pub-id></mixed-citation>
</ref>
<ref id="ref79">
<label>79.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Callahan</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Modesto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Meira</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Seymen</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Patir</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Vieira</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>) <article-title>Axis inhibition protein 2 (AXIN2) polymorphisms and tooth agenesis</article-title>. <source/>Arch. Oral Biol., <volume>54</volume>, <fpage>45</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">18790474</pub-id></mixed-citation>
</ref>
<ref id="ref80">
<label>80.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mostowska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Biedziak</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Jagodzinski</surname><given-names>P.P.</given-names></name></person-group> (<year>2006</year>) <article-title>Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis</article-title>. <source/>J. Hum. Genet., <volume>51</volume>, <fpage>262</fpage>.<pub-id pub-id-type="pmid">16432638</pub-id></mixed-citation>
</ref>
<ref id="ref81">
<label>81.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>) <article-title>WNT10A variants are associated with non-syndromic tooth agenesis in the general population</article-title>. <source/>Hum. Genet., <volume>133</volume>, <fpage>117</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">24043634</pub-id></mixed-citation>
</ref>
<ref id="ref82">
<label>82.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mues</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Bonds</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Vieira</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Seymen</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>O.</given-names></name> and <name name-style="western"><surname>D'souza</surname><given-names>R.N.</given-names></name></person-group> (<year>2014</year>) <article-title>The WNT10A gene in ectodermal dysplasias and selective tooth agenesis</article-title>. <source/>Am. J. Med. Genet. A, <volume>164</volume>, <fpage>2455</fpage>–<lpage>2460</lpage>.</mixed-citation>
</ref>
<ref id="ref83">
<label>83.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>van den Boogaard</surname><given-names>M.-J.</given-names></name>, <name name-style="western"><surname>Créton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bronkhorst</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>van der Hout</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hennekam</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lindhout</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cune</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>van Amstel</surname><given-names>H.K.P.</given-names></name></person-group> (<year>2012</year>) <article-title>Mutations in WNT10A are present in more than half of isolated hypodontia cases</article-title>. <source/>J. Med. Genet., <volume>49</volume>, <fpage>327</fpage>–<lpage>331</lpage>.<pub-id pub-id-type="pmid">22581971</pub-id></mixed-citation>
</ref>
<ref id="ref84">
<label>84.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mostowska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Biedziak</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zadurska</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dunin-Wilczynska</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Lianeri</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Jagodzinski</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>) <article-title>Nucleotide variants of genes encoding components of the Wnt signalling pathway and the risk of non-syndromic tooth agenesis</article-title>. <source/>Clin. Genet., <volume>84</volume>, <fpage>429</fpage>–<lpage>440</lpage>.<pub-id pub-id-type="pmid">23167694</pub-id></mixed-citation>
</ref>
<ref id="ref85">
<label>85.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lungova</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Verheyden</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name> and <name name-style="western"><surname>Thibeault</surname><given-names>S.L.</given-names></name></person-group> (<year>2018</year>) <article-title>β-Catenin signaling is essential for mammalian larynx recanalization and the establishment of vocal fold progenitor cells</article-title>. <source/>Development, <volume>145</volume><comment>, pii: dev157677</comment>.</mixed-citation>
</ref>
<ref id="ref86">
<label>86.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J.I.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jun</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hikasa</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>S.Y.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2006</year>) <article-title>Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct catenin subfamilies promote Wnt signals</article-title>. <source/>Dev. Cell, <volume>11</volume>, <fpage>683</fpage>–<lpage>695</lpage>.<pub-id pub-id-type="pmid">17084360</pub-id></mixed-citation>
</ref>
<ref id="ref87">
<label>87.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J.-I.</given-names></name>, <name name-style="western"><surname>Spring</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Sater</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Otchere</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Daniel</surname><given-names>J.M.</given-names></name> and <name name-style="western"><surname>McCrea</surname><given-names>P.D.</given-names></name></person-group> (<year>2004</year>) <article-title>Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin</article-title>. <source/>Nat. Cell Biol., <volume>6</volume>, <fpage>1212</fpage>.<pub-id pub-id-type="pmid">15543138</pub-id></mixed-citation>
</ref>
<ref id="ref88">
<label>88.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Buckingham</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meilhac</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Zaffran</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>) <article-title>Building the mammalian heart from two sources of myocardial cells</article-title>. <source/>Nat. Rev. Genet., <volume>6</volume>, <fpage>826</fpage>.<pub-id pub-id-type="pmid">16304598</pub-id></mixed-citation>
</ref>
<ref id="ref89">
<label>89.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Srivastava</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Kirby</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Olson</surname><given-names>E.N.</given-names></name></person-group> (<year>1997</year>) <article-title>Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND</article-title>. <source/>Nat. Genet., <volume>16</volume>, <fpage>154</fpage>.<pub-id pub-id-type="pmid">9171826</pub-id></mixed-citation>
</ref>
<ref id="ref90">
<label>90.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kochilas</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Merscher-Gomez</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Potluri</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kucherlapati</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Morrow</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Epstein</surname><given-names>J.A.</given-names></name></person-group> (<year>2002</year>) <article-title>The role of neural crest during cardiac development in a mouse model of DiGeorge syndrome</article-title>. <source/>Dev. Biol., <volume>251</volume>, <fpage>157</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">12413905</pub-id></mixed-citation>
</ref>
<ref id="ref91">
<label>91.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Eley</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Alqahtani</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>MacGrogan</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>R.V.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Salguero-Jimenez</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sintes Rodriguez San Pedro</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tiurma</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McCutcheon</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gilmore</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>) <article-title>A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice</article-title>. <source/>Elife, <volume>7</volume>, pii:<fpage>e34110</fpage>.<pub-id pub-id-type="pmid">29956664</pub-id></mixed-citation>
</ref>
<ref id="ref92">
<label>92.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Chughtai</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wisse</surname><given-names>L.J.</given-names></name>, <name name-style="western"><surname>Gittenberger-de Groot</surname><given-names>A.C.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Goumans</surname><given-names>M.-J.T.</given-names></name>, <name name-style="western"><surname>VanMunsteren</surname><given-names>J.C.</given-names></name>, <name name-style="western"><surname>Jongbloed</surname><given-names>M.R.</given-names></name> and <name name-style="western"><surname>DeRuiter</surname><given-names>M.C.</given-names></name></person-group> (<year>2018</year>) <article-title>Nos3 mutation leads to abnormal neural crest cell and second heart field lineage patterning in bicuspid aortic valve formation</article-title>. <source/>Dis. Model. Mech., <volume>11</volume>(10), pii:dmm.</mixed-citation>
</ref>
<ref id="ref93">
<label>93.</label>
<mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Fahed</surname><given-names>A.C.</given-names></name> and <name name-style="western"><surname>Nemer</surname><given-names>G.M.</given-names></name></person-group> (<year>2012</year>) <chapter-title>Genetic causes of syndromic and non-syndromic congenital heart disease</chapter-title> In <source/>Mutations in Human Genetic Disease. IntechOpen, London UK.</mixed-citation>
</ref>
<ref id="ref94">
<label>94.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Smalley-Freed</surname><given-names>W.G.</given-names></name>, <name name-style="western"><surname>Efimov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Burnett</surname><given-names>P.E.</given-names></name>, <name name-style="western"><surname>Short</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Gumucio</surname><given-names>D.L.</given-names></name>, <name name-style="western"><surname>Washington</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Coffey</surname><given-names>R.J.</given-names></name> and <name name-style="western"><surname>Reynolds</surname><given-names>A.B.</given-names></name></person-group> (<year>2010</year>) <article-title>p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice</article-title>. <source/>J. Clin. Invest., <volume>120</volume>, <fpage>1824</fpage>–<lpage>1835</lpage>.<pub-id pub-id-type="pmid">20484816</pub-id></mixed-citation>
</ref>
<ref id="ref95">
<label>95.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lehman</surname><given-names>H.L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Welsh</surname><given-names>P.A.</given-names></name> and <name name-style="western"><surname>Stairs</surname><given-names>D.B.</given-names></name></person-group> (<year>2015</year>) <article-title>p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma</article-title>. <source/>Am. J. Pathol., <volume>185</volume>, <fpage>240</fpage>–<lpage>251</lpage>.<pub-id pub-id-type="pmid">25529795</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>